Consolidated Financial Statements |
Consolidated Statement of Financial Position |
||||||||||||
As at October 31 ($ millions) | Note |
2023 |
2022 |
|||||||||
Assets |
||||||||||||
Cash and deposits with financial institutions |
6 | $ |
$ | |||||||||
Precious metals |
||||||||||||
Trading assets |
||||||||||||
Securities |
8 | (a) | ||||||||||
Loans |
8 | (b) | ||||||||||
Other |
||||||||||||
Securities purchased under resale agreements and securities borrowed |
||||||||||||
Derivative financial instruments |
10 | |||||||||||
Investment securities |
12 | |||||||||||
Loans |
||||||||||||
Residential mortgages |
13 | |||||||||||
Personal loans |
13 | |||||||||||
Credit cards |
13 | |||||||||||
Business and government |
13 | |||||||||||
Allowance for credit losses |
13 | (e) | ||||||||||
Other |
||||||||||||
Customers’ liability under acceptances, net of allowance |
||||||||||||
Property and equipment |
16 | |||||||||||
Investments in associates |
17 | |||||||||||
Goodwill and other intangible assets |
18 | |||||||||||
Deferred tax assets |
27 | (c) | ||||||||||
Other assets |
19 | |||||||||||
$ |
$ | |||||||||||
Liabilities |
||||||||||||
Deposits |
||||||||||||
Personal |
20 | $ |
$ | |||||||||
Business and government |
20 | |||||||||||
Financial institutions |
20 | |||||||||||
Financial instruments designated at fair value through profit or loss |
9 | |||||||||||
Other |
||||||||||||
Acceptances |
||||||||||||
Obligations related to securities sold short |
||||||||||||
Derivative financial instruments |
10 | |||||||||||
Obligations related to securities sold under repurchase agreements and securities lent |
||||||||||||
Subordinated debentures |
21 | |||||||||||
Other liabilities |
22 | |||||||||||
Equity |
||||||||||||
Common equity |
||||||||||||
Common shares |
24 | (a) | ||||||||||
Retained earnings |
||||||||||||
Accumulated other comprehensive income (loss) |
( |
) |
( |
) | ||||||||
Other reserves |
( |
) |
( |
) | ||||||||
Total common equity |
||||||||||||
Preferred shares and other equity instruments |
24 | (b) | ||||||||||
Total equity attributable to equity holders of the Bank |
||||||||||||
Non-controlling interests in subsidiaries |
31 | (b) | ||||||||||
$ |
$ | |
Aaron W. Regent |
Scott Thomson |
|||
Chairman of the Board | President and Chief Executive Officer |
For the year ended October 31 ($ millions) | Note |
2023 |
2022 |
|||||||||
Revenue |
||||||||||||
Interest income (1) |
32 | |||||||||||
Loans |
$ |
$ | |
|||||||||
Securities |
||||||||||||
Securities purchased under resale agreements and securities borrowed |
||||||||||||
Deposits with financial institutions |
||||||||||||
Interest expense |
32 | |||||||||||
Deposits |
||||||||||||
Subordinated debentures |
||||||||||||
Other |
||||||||||||
Net interest income |
||||||||||||
Non-interest income |
||||||||||||
Card revenues |
||||||||||||
Banking services fees |
||||||||||||
Credit fees |
||||||||||||
Mutual funds |
||||||||||||
Brokerage fees |
||||||||||||
Investment management and trust |
||||||||||||
Underwriting and advisory fees |
||||||||||||
Non-trading foreign exchange |
||||||||||||
Trading revenues |
||||||||||||
Net gain on sale of investment securities |
12 | (e) | ||||||||||
Net income from investments in associated corporations |
17 | |||||||||||
Insurance underwriting income, net of claims |
||||||||||||
Other fees and commissions |
||||||||||||
Other |
||||||||||||
Total revenue |
||||||||||||
Provision for credit losses |
13 | (e) | ||||||||||
Non-interest expenses |
||||||||||||
Salaries and employee benefits |
||||||||||||
Premises and technology |
||||||||||||
Depreciation and amortization |
||||||||||||
Communications |
||||||||||||
Advertising and business development |
||||||||||||
Professional |
||||||||||||
Business and capital taxes |
||||||||||||
Other |
||||||||||||
Income before taxes |
||||||||||||
Income tax expense |
27 | |||||||||||
Net income |
$ |
$ | ||||||||||
Net income attributable to non-controlling interests in subsidiaries |
31 | (b) | ||||||||||
Net income attributable to equity holders of the Bank |
$ |
$ | ||||||||||
Preferred shareholders and other equity instrument holders |
||||||||||||
Common shareholders |
$ |
$ | ||||||||||
Earnings per common share (in dollars) |
||||||||||||
Basic |
33 | $ |
$ | |||||||||
Diluted |
33 | |||||||||||
Dividends paid per common share (in dollars) |
24 | (a) |
(1) | Includes interest income on financial assets measured at amortized cost and FVOCI, calculated using the effective interest method, of $ |
For the year ended October 31 ($ millions) | 2023 |
2022 |
||||||
Net income |
$ |
$ | |
|||||
Other comprehensive income (loss) |
||||||||
Items that will be reclassified subsequently to net income |
||||||||
Net change in unrealized foreign currency translation gains (losses): |
||||||||
Net unrealized foreign currency translation gains (losses) |
||||||||
Net gains (losses) on hedges of net investments in foreign operations |
( |
) |
( |
) | ||||
Income tax expense (benefit): |
||||||||
Net unrealized foreign currency translation gains (losses) |
||||||||
Net gains (losses) on hedges of net investments in foreign operations |
( |
) |
( |
) | ||||
Net change in fair value due to change in debt instruments measured at fair value through other comprehensive income: |
||||||||
Net gains (losses) in fair value |
( |
) | ||||||
Reclassification of net (gains) losses to net income |
||||||||
Income tax expense (benefit): |
||||||||
Net gains (losses) in fair value |
( |
) | ||||||
Reclassification of net (gains) losses to net income |
||||||||
( |
) | |||||||
Net change in gains (losses) on derivative instruments designated as cash flow hedges: |
||||||||
Net gains (losses) on derivative instruments designated as cash flow hedges |
( |
) | ||||||
Reclassification of net (gains) losses to net income |
( |
) |
||||||
Income tax expense (benefit): |
||||||||
Net gains (losses) on derivative instruments designated as cash flow hedges |
( |
) | ||||||
Reclassification of net (gains) losses to net income |
( |
) |
||||||
( |
) | |||||||
Other comprehensive income (loss) from investments in associates |
( |
) |
( |
) | ||||
Items that will not be reclassified subsequently to net income |
||||||||
Net change in remeasurement of employee benefit plan asset and liability: |
||||||||
Actuarial gains (losses) on employee benefit plans |
||||||||
Income tax expense (benefit) |
( |
) |
||||||
Net change in fair value due to change in equity instruments designated at fair value through other comprehensive income: |
||||||||
Net gains (losses) in fair value |
( |
) |
( |
) | ||||
Income tax expense (benefit) |
( |
) |
( |
) | ||||
( |
) |
( |
) | |||||
Net change in fair value due to change in own credit risk on financial liabilities designated under the fair value option: |
||||||||
Change in fair value due to change in own credit risk on financial liabilities designated under the fair value option |
( |
) |
||||||
Income tax expense (benefit) |
( |
) |
||||||
( |
) |
|||||||
Other comprehensive income (loss) from investments in associates |
||||||||
Other comprehensive income (loss) |
( |
) | ||||||
Comprehensive income |
$ |
$ | ||||||
Comprehensive income (loss) attributable to non-controlling interests |
||||||||
Comprehensive income attributable to equity holders of the Bank |
$ |
$ | ||||||
Preferred shareholders and other equity instrument holders |
||||||||
Common shareholders |
$ |
$ |
Accumulated other comprehensive income (loss) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
($ millions) | Common shares (Note 24) |
Retained earnings (1) |
Foreign currency translation |
Debt instruments FVOCI |
Equity instruments FVOCI |
Cash flow hedges |
Other (2) |
Other reserves |
Total common equity |
Preferred shares and other equity instruments (Note 24) |
Total attributable to equity holders |
Non- controlling interests in subsidiaries (Note 31(b)) |
Total |
|||||||||||||||||||||||||||||||||||||||
Balance as at October 31, 2022 |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||||||||||
Net income |
– |
– |
– |
– |
– |
– |
– |
|||||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income (loss) |
– |
– |
( |
) |
( |
) |
– |
– |
||||||||||||||||||||||||||||||||||||||||||||
Total comprehensive income |
$ |
– |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
– |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||||||||||||
Shares/instruments issued |
– |
– |
– |
– |
– |
– |
( |
) |
– |
– |
||||||||||||||||||||||||||||||||||||||||||
Shares repurchased/redeemed |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
|||||||||||||||||||||||||||||||||||||||
Dividends and distributions paid to equity holders |
– |
( |
) |
– |
– |
– |
– |
– |
– |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | |||||||||||||||||||||||||||||||||
Share-based payments (3) |
– |
– |
– |
– |
– |
– |
– |
– |
– |
|||||||||||||||||||||||||||||||||||||||||||
Other |
– |
( |
) |
( |
) |
– |
( |
) |
– |
– |
( |
) |
– |
|||||||||||||||||||||||||||||||||||||||
Balance as at October 31, 2023 |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||||||||||
Balance as at October 31, 2021 |
$ | $ | $ | ( |
) | $ | ( |
) | $ | $ | ( |
) | $ | ( |
) | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||
Net income |
– | – | – | – | – | – | – | |||||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income (loss) |
– | – | ( |
) | ( |
) | ( |
) | – | ( |
) | – | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||
Total comprehensive income |
$ | – | $ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | $ | – | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||
Shares/instruments issued |
– | – | – | – | – | – | ( |
) | – | |||||||||||||||||||||||||||||||||||||||||||
Shares repurchased/redeemed |
( |
) | ( |
) | – | – | – | – | – | – | ( |
) | ( |
) | ( |
) | – | ( |
) | |||||||||||||||||||||||||||||||||
Dividends and distributions paid to equity holders |
– | ( |
) | – | – | – | – | – | – | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | |||||||||||||||||||||||||||||||||
Share-based payments (3) |
– | – | – | – | – | – | – | – | – | |||||||||||||||||||||||||||||||||||||||||||
Other |
– | ( |
) | ( |
) | – | ( |
) | ( |
) | – | ( |
) (4) |
( |
) | – | ( |
) | ( |
) (4) |
( |
) | ||||||||||||||||||||||||||||||
Balance as at October 31, 2022 |
$ | |
$ | |
$ | ( |
) | $ | ( |
) | $ | |
$ | ( |
) | $ | |
$ | ( |
) | $ | |
$ | |
$ | |
$ | |
$ | |
(1) | Includes undistributed retained earnings of $ |
(2) | Includes Share from associates, Employee benefits and Own credit risk. |
(3) | Represents amounts on account of share-based payments (refer to Note 26). |
(4) |
Includes changes to non-controlling interests arising from business combinations and related transactions (refer to Note 36). |
Sources (uses) of cash flows for the year ended October 31 ($ millions) | 2023 |
2022 |
||||||
Cash flows from operating activities |
||||||||
Net income |
$ |
$ |
||||||
Adjustment for: |
||||||||
Net interest income |
( |
) |
( |
) | ||||
Depreciation and amortization |
||||||||
Provision for credit losses |
||||||||
Impairment on investments in associates |
– | |||||||
Equity-settled share-based payment expense |
||||||||
Net gain on sale of investment securities |
( |
) |
( |
) | ||||
Net (gain)/loss on divestitures |
( |
) |
||||||
Net income from investments in associated corporations |
( |
) |
( |
) | ||||
Income tax expense |
||||||||
Changes in operating assets and liabilities: |
||||||||
Trading assets |
( |
) |
||||||
Securities purchased under resale agreements and securities borrowed |
( |
) |
( |
) | ||||
Loans |
( |
) | ||||||
Deposits |
||||||||
Obligations related to securities sold short |
( |
) |
( |
) | ||||
Obligations related to securities sold under repurchase agreements and securities lent |
||||||||
Net derivative financial instruments |
||||||||
Other, net |
( |
) |
( |
) | ||||
Dividends received |
||||||||
Interest received |
||||||||
Interest paid |
( |
) |
( |
) | ||||
Income tax paid |
( |
) |
( |
) | ||||
Net cash from/(used in) operating activities |
||||||||
Cash flows from investing activities |
||||||||
Interest-bearing deposits with financial institutions |
( |
) |
||||||
Purchase of investment securities |
( |
) |
( |
) | ||||
Proceeds from sale and maturity of investment securities |
||||||||
Acquisition/divestiture of subsidiaries, associated corporations or business units, net of cash acquired |
( |
) | ||||||
Property and equipment, net of disposals |
( |
) |
( |
) | ||||
Other, net |
( |
) |
( |
) | ||||
Net cash from/(used in) investing activities |
( |
) |
( |
) | ||||
Cash flows from financing activities |
||||||||
Proceeds from issue of subordinated debentures |
||||||||
Redemption of subordinated debentures |
( |
) |
( |
) | ||||
Proceeds from preferred shares and other equity instruments issued |
– |
|||||||
Redemption of preferred shares |
– |
( |
) | |||||
Proceeds from common shares issued |
||||||||
Common shares purchased for cancellation |
– |
( |
) | |||||
Cash dividends and distributions paid |
( |
) |
( |
) | ||||
Distributions to non-controlling interests |
( |
) |
( |
) | ||||
Payment of lease liabilities |
( |
) |
( |
) | ||||
Other, net |
( |
) | ||||||
Net cash from/(used in) financing activities |
( |
) |
( |
) | ||||
Effect of exchange rate changes on cash and cash equivalents |
||||||||
Net change in cash and cash equivalents |
( |
) |
||||||
Cash and cash equivalents at beginning of year (1) |
||||||||
Cash and cash equivalents at end of year (1) |
$ |
$ | |
(1) |
Represents cash and non-interest-bearing deposits with financial institutions (refer to Note 6). |
Notes to the 2023 Consolidated Financial Statements |
Page | Note | |||
205 | 19 | Other assets | ||
205 | 20 | Deposits | ||
206 | 21 | Subordinated debentures | ||
206 | 22 | Other liabilities | ||
207 | 23 | Provisions | ||
207 | 24 | Common shares, preferred shares and other equity instruments | ||
210 | 25 | Capital management | ||
211 | 26 | Share-based payments | ||
213 | 27 | Corporate income taxes | ||
215 | 28 | Employee benefits | ||
221 | 29 | Operating segments | ||
222 | 30 | Related party transactions | ||
224 | 31 | Principal subsidiaries and non-controlling interests in subsidiaries | ||
225 | 32 | Interest income and expense | ||
225 | 33 | Earnings per share | ||
226 | 34 | Guarantees, commitments and pledged assets | ||
227 | 35 | Financial instruments – risk management | ||
234 | 36 | Acquisitions and divestitures |
1 |
Reporting Entity |
2 |
Basis of Preparation |
• | Financial assets and liabilities measured at fair value through profit or loss |
• | Financial assets and liabilities designated at fair value through profit or loss |
• | Derivative financial instruments |
• | Equity instruments designated at fair value through other comprehensive income |
• | Debt instruments measured at fair value through other comprehensive income |
Allowance for credit losses |
Note 3 | |
Note 13(e) | ||
Fair value of financial instruments |
Note 3 | |
Note 7 | ||
Corporate income taxes |
Note 3 | |
Note 27 | ||
Employee benefits |
Note 3 | |
Note 28 | ||
Goodwill and intangible assets |
Note 3 | |
Note 18 | ||
Fair value of all identifiable assets and liabilities as a result of business combinations |
Note 3 | |
Note 36 | ||
Impairment of investment securities |
Note 3 | |
Note 12 | ||
Impairment of non-financial assets |
Note 3 | |
Note 16 | ||
Structured entities |
Note 3 | |
Note 15 | ||
De facto control of other entities |
Note 3 | |
Note 31 | ||
Derecognition of financial assets and liabilities |
Note 3 | |
Note 14 | ||
Provisions |
Note 3 | |
Note 23 |
3 |
Significant Accounting Policies |
• | power over the investee; |
• | exposure, or rights, to variable returns from involvement with the investee; and |
• | the ability to use power over the investee to affect the amount of the Bank’s returns. |
• | by virtue of an agreement, over more than half of the voting rights; |
• | to govern the financial and operating policies of the entity under a statute or an agreement; |
• | to appoint or remove the majority of the members of the board of directors or equivalent governing body and control of the entity is by that board or body; or |
• | to govern the financial and operating policies of the entity through the size of its holding of voting rights relative to the size and dispersion of holding of the other vote holders and voting patterns at shareholder meetings (i.e., de facto control). |
• | Amortized cost; |
• | Fair value through other comprehensive income (FVOCI); |
• | Fair value through profit or loss (FVTPL); |
• | Elected at fair value through other comprehensive income (Equities only); or |
• | Designated at FVTPL |
• | Amortized cost; |
• | Fair value through other comprehensive income (FVOCI); |
• | Fair value through profit or loss (FVTPL); or |
• | Designated at FVTPL |
(i) | The business model under which the asset is held; and |
(ii) | The contractual cash flow characteristics of the instrument . |
• | Held to collect: The objective of this business model is to hold assets and collect contractual cash flows. Any sales of the asset are incidental to the objective of the model. |
• | Held to collect and for sale: Both collecting contractual cash flows and sales are integral to achieving the objectives of the business model. |
• | Other business model: The business model is neither held-to-collect held-to-collect |
• | How the performance of assets in a portfolio is evaluated and reported to group heads and other key decision makers within the Bank’s business lines; |
• | How compensation is determined for the Bank’s business lines’ management that manages the assets; |
• | How the business lines’ management is compensated for managing the Bank’s assets based on the fair value or the contractual cash flows collected; |
• | Whether the assets are held for trading purposes; |
• | The risks that affect the performance of assets held within a business model and how those risks are managed; and |
• | The frequency and volume of sales in prior periods and expectations about future sales activity. |
(i) | are held for trading purposes; |
(ii) | are held as part of a portfolio managed on a fair value basis; or |
(iii) | whose cash flows do not represent payments that are solely payments of principal and interest. |
• | Fair value through profit or loss (FVTPL); or |
• | Elected at fair value through other comprehensive income (FVOCI). |
• | Fair value through profit or loss (FVTPL); |
• | Amortized cost; or |
• | Designated at FVTPL. |
• | The designation eliminates or significantly reduces an accounting mismatch which would otherwise arise; or |
• | A group of financial liabilities are managed and their performance is evaluated on a fair value basis, in line with a documented risk management strategy; or |
• | The financial liability contains one or more embedded derivatives which significantly modify the cash flows otherwise required. |
• | Amortized cost financial assets; |
• | Debt securities classified as at FVOCI; |
• | Off-balance sheet loan commitments; and |
• | Financial guarantee contracts. |
• | Stage 1 – Where there has not been a significant increase in credit risk (SIR) since initial recognition of a financial instrument, an amount equal to 12 months expected credit loss is recorded. The expected credit loss is computed using a probability of default occurring over the next 12 months. For those instruments with a remaining maturity of less than 12 months, a probability of default corresponding to remaining term to maturity is used. |
• | Stage 2 – When a financial instrument experiences a SIR subsequent to origination but is not considered to be in default, it is included in Stage 2. This requires the computation of expected credit loss based on the probability of default over the remaining estimated life of the financial instrument. |
• | Stage 3 – Financial instruments that are considered to be in default are included in this stage. Similar to Stage 2, the allowance for credit losses captures the lifetime expected credit losses. |
• | PD – The probability of default is an estimate of the likelihood of default over a given time horizon. A default may only happen at a certain time over the remaining estimated life if the facility has not been previously derecognized and is still in the portfolio. |
• | EAD – The exposure at default is an estimate of the exposure at a future default date, considering expected changes in the exposure after the reporting date, including repayments of principal and interest, whether scheduled by contract or otherwise, expected drawdowns on committed facilities, and accrued interest from missed payments. |
• | LGD – The loss given default is an estimate of the loss arising in the case where a default occurs at a given time. It is based on the difference between the contractual cash flows due and those that the lender would expect to receive, including from the realization of any collateral. It is usually expressed as a percentage of the EAD. |
• | Financial assets measured at amortized cost: as a deduction from the gross carrying amount of the financial assets; |
• | Debt instruments measured at fair value through other comprehensive income: no allowance is recognized in the Statement of Financial Position because the carrying value of these assets is their fair value. However, the allowance determined is presented in the accumulated other comprehensive income; |
• | Off-balance sheet credit risks include undrawn lending commitments, letters of credit and letters of guarantee: as a provision in other liabilities. |
• | significant financial difficulty of the borrower; |
• | default or delinquency in interest or principal payments; |
• | high probability of the borrower entering a phase of bankruptcy or a financial reorganization; |
• | measurable decrease in the estimated future cash flows from the loan or the underlying assets that back the loan. |
• | their economic characteristics and risks are not closely related to those of the host contract; |
• | a separate instrument with the same terms as the embedded derivative would meet the definition of a derivative; and |
• | the combined contract is not held for trading or designated at fair value through profit or loss. |
• | Contingent liabilities, until resolved, are measured at the higher of the amount that would be recognized as a provision or the amount initially recognized, with any change recognized in the Consolidated Statement of Income. |
• | Indemnification assets are measured on the same basis as the item to which the indemnification relates. |
• | Contingent consideration classified as a liability is measured at fair value, with any change recognized in the Consolidated Statement of Income. |
• | Liabilities to non-controlling interest holders when remeasured at the end of each reporting period, a corresponding change is recorded in equity. |
4 |
Interest Rate Benchmark Reform |
Carrying Amount |
||||||||
($ millions) |
As at October 31, 2023 |
As at October 31, 2022 |
||||||
CDOR Maturing after June 28, 2024 |
CDOR Maturing after June 28, 2024 |
|||||||
Non-derivative financial assets(1) |
$ |
$ | |
|||||
Non-derivative financial liabilities(2) |
(1) | Non derivative financial assets include carrying amounts of debt securities, loans and customer’s liability under acceptances (debt securities, loans and customer’s liability under acceptances measured at amortized cost are gross of allowance for credit losses). |
(2) | Non-derivative financial liabilities include carrying amounts of deposits, acceptances, obligations related to securities sold short, subordinated debentures and other liabilities. |
Notional Amount |
||||||||
($ millions) |
As at October 31, 2023 |
As at October 31, 2022 |
||||||
CDOR Maturing after June 28, 2024 |
CDOR Maturing after June 28, 2024 |
|||||||
Derivatives |
||||||||
Single currency interest rate swaps (1) |
$ |
$ | |
|||||
Cross currency interest rate swaps (1) |
||||||||
Other (2) |
||||||||
Undrawn commitments |
(1) | For single currency and/or cross currency interest rate swaps, where both legs are referencing rates directly impacted by the interest rate benchmark reform, the relevant notional amount for both legs are included to reflect the risks relating to the reform for each rate. |
(2) | Other derivatives include futures, total return swaps and options. |
($ millions) | As at October 31, 2023 |
As at October 31, 2022 |
||||||
CDOR Maturing after June 28, 2024 (1) |
CDOR Maturing after June 28, 2024 (1) |
|||||||
Hedging derivatives (2) |
$ |
$ | |
(1) | For single currency interest rate swaps, where both legs are referencing rates directly impacted by the interest rate benchmark reform, the relevant notional amount for both legs are included to reflect the risks relating to the reform for each rate. |
(2) | For cross currency swaps where a CAD float leg is inserted to create two separate hedging instruments, the relevant notional amount for both instruments are included in the table. |
5 |
Future Accounting Developments |
6 |
Cash and Deposits with Financial Institutions |
As at October 31 ($ millions) |
2023 |
2022 |
||||||
Cash and non-interest-bearing deposits with financial institutions |
$ |
$ |
||||||
Interest-bearing deposits with financial institutions |
||||||||
Total |
$ |
(1) |
$ |
(1) |
(1) | Net of allowances of $ |
7 |
Fair Value of Financial Instruments |
• | Canadian fixed rate residential mortgages are fair valued by discounting the expected future contractual cash flows, taking into account expected prepayments and using management’s best estimate of average market interest rates currently offered for mortgages with similar remaining terms. |
• | For fixed rate business and government loans, fair value is determined by discounting the expected future contractual cash flows of these loans at interest rates estimated by using the appropriate currency swap curves for the remaining term, adjusted for a credit mark of the expected losses in the portfolio. |
• | For all other fixed rate loans, fair value is determined by discounting the expected future contractual cash flows of these loans at interest rates estimated by using the appropriate currency swap curves for the remaining term. |
• | For all floating rate loans fair value is assumed to equal book value. |
2023 |
2022 |
|||||||||||||||
As at October 31 ($ millions) |
Total fair value |
Total carrying value |
Total fair value |
Total carrying value |
||||||||||||
Assets: |
||||||||||||||||
Cash and deposits with financial institutions |
$ |
$ |
$ |
$ |
||||||||||||
Trading assets |
||||||||||||||||
Securities purchased under resale agreements and securities borrowed |
||||||||||||||||
Derivative financial instruments |
||||||||||||||||
Investment securities – FVOCI and FVTPL |
||||||||||||||||
Investment securities – Amortized cost |
||||||||||||||||
Loans |
||||||||||||||||
Customers’ liability under acceptances |
||||||||||||||||
Other financial assets |
||||||||||||||||
Liabilities: |
||||||||||||||||
Deposits |
||||||||||||||||
Financial instruments designated at fair value through profit or loss |
||||||||||||||||
Acceptances |
||||||||||||||||
Obligations related to securities sold short |
||||||||||||||||
Derivative financial instruments |
||||||||||||||||
Obligations related to securities sold under repurchase agreements and securities lent |
||||||||||||||||
Subordinated debentures |
||||||||||||||||
Other financial liabilities |
2023 |
2022 |
|||||||||||||||||||||||||||||||
As at October 31 ($ millions) |
Level 1 |
Level 2 |
Level 3 |
Total |
Level 1 |
Level 2 |
Level 3 |
Total |
||||||||||||||||||||||||
Instruments carried at fair value on a recurring basis: |
||||||||||||||||||||||||||||||||
Assets: |
||||||||||||||||||||||||||||||||
Precious metals (1) |
$ |
– |
$ |
$ |
– |
$ |
$ |
– |
$ |
$ |
– |
$ |
||||||||||||||||||||
Trading assets |
||||||||||||||||||||||||||||||||
Loans |
– |
– |
– |
|||||||||||||||||||||||||||||
Canadian federal government and government guaranteed debt |
– |
– |
||||||||||||||||||||||||||||||
Canadian provincial and municipal debt |
– |
– |
||||||||||||||||||||||||||||||
U.S. treasury and other U.S. agencies’ debt |
– |
– |
– |
– |
||||||||||||||||||||||||||||
Other foreign governments’ debt |
– |
– |
||||||||||||||||||||||||||||||
Corporate and other debt |
– |
|||||||||||||||||||||||||||||||
Equity securities |
||||||||||||||||||||||||||||||||
Other |
– |
– |
– |
– |
||||||||||||||||||||||||||||
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||||
Investment securities (2) |
||||||||||||||||||||||||||||||||
Canadian federal government and government guaranteed debt |
$ |
$ |
$ |
– |
$ |
$ |
$ |
$ |
– |
$ |
||||||||||||||||||||||
Canadian provincial and municipal debt |
– |
– |
||||||||||||||||||||||||||||||
U.S. treasury and other U.S. agencies’ debt |
– |
– |
||||||||||||||||||||||||||||||
Other foreign governments’ debt |
– |
– |
||||||||||||||||||||||||||||||
Corporate and other debt |
– |
|||||||||||||||||||||||||||||||
Equity securities |
||||||||||||||||||||||||||||||||
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||||
Derivative financial instruments |
||||||||||||||||||||||||||||||||
Interest rate contracts |
$ |
– |
$ |
$ |
– |
$ |
$ |
– |
$ |
$ |
$ |
|||||||||||||||||||||
Foreign exchange and gold contracts |
– |
– |
– |
|||||||||||||||||||||||||||||
Equity contracts |
||||||||||||||||||||||||||||||||
Credit contracts |
– |
– |
– |
|||||||||||||||||||||||||||||
Commodity contracts |
– |
– |
||||||||||||||||||||||||||||||
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||||
Liabilities: |
||||||||||||||||||||||||||||||||
Deposits (3) |
$ |
– |
$ |
( |
) |
$ |
– |
$ |
( |
) |
$ |
– |
$ |
$ |
– |
$ |
||||||||||||||||
Financial liabilities designated at fair value through profit or loss |
– |
– |
– |
– |
||||||||||||||||||||||||||||
Obligations related to securities sold short |
– |
|||||||||||||||||||||||||||||||
Derivative financial instruments |
||||||||||||||||||||||||||||||||
Interest rate contracts |
– |
– |
||||||||||||||||||||||||||||||
Foreign exchange and gold contracts |
– |
– |
– |
– |
||||||||||||||||||||||||||||
Equity contracts |
||||||||||||||||||||||||||||||||
Credit contracts |
– |
– |
– |
|||||||||||||||||||||||||||||
Commodity contracts |
– |
– |
||||||||||||||||||||||||||||||
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||||
Instruments not carried at fair value (4) : |
||||||||||||||||||||||||||||||||
Assets: |
||||||||||||||||||||||||||||||||
Investment securities – amortized cost |
$ |
$ |
$ |
– |
$ |
$ |
$ |
$ |
– |
$ |
||||||||||||||||||||||
Loans (5) |
– |
– |
– |
– |
||||||||||||||||||||||||||||
Liabilities: |
||||||||||||||||||||||||||||||||
Deposits (5) |
– |
– |
– |
– |
||||||||||||||||||||||||||||
Subordinated debentures |
– |
– |
– |
– |
||||||||||||||||||||||||||||
Other liabilities |
– |
– |
– |
(1) | The fair value of precious metals is determined based on quoted market prices and forward spot prices, where applicable, less the cost to sell. |
(2) | Excludes debt investment securities measured at amortized cost of $ |
(3) |
(4) |
Represents the fair value of financial assets and liabilities where the carrying amount is not a reasonable approximation of fair value. |
(5) |
Represents fixed rate instruments. |
As at October 31, 2023 |
||||||||||||||||||||||||||||||||
($ millions) |
Fair value November 1 2022 |
Gains/(losses) recorded in income |
Gains/(losses) recorded in OCI |
Purchases/ Issuances |
Sales/ Settlements |
Transfers into/out of Level 3 |
Fair value October 31 2023 |
Change in unrealized gains/(losses) recorded in income for instruments still held (1) |
||||||||||||||||||||||||
Trading assets |
||||||||||||||||||||||||||||||||
Loans |
$ |
– |
$ |
– |
$ |
– |
$ |
$ |
– |
$ |
( |
) |
$ |
$ |
– |
|||||||||||||||||
Corporate and other debt |
– |
– |
– |
– |
( |
) |
– |
– |
||||||||||||||||||||||||
Equity securities |
– |
– |
( |
) |
– |
|||||||||||||||||||||||||||
– |
– |
( |
) |
– |
||||||||||||||||||||||||||||
Investment securities |
||||||||||||||||||||||||||||||||
Corporate and other debt |
( |
) |
– |
( |
) |
– |
( |
) | ||||||||||||||||||||||||
Equity securities |
( |
) |
( |
) |
||||||||||||||||||||||||||||
( |
) |
( |
) |
|||||||||||||||||||||||||||||
Derivative financial instruments – assets |
||||||||||||||||||||||||||||||||
Interest rate contracts |
( |
) |
– |
( |
) |
( |
) |
– |
( |
) | ||||||||||||||||||||||
Foreign exchange and gold contracts |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||
Equity contracts |
( |
) |
– |
( |
) |
( |
) (2) | |||||||||||||||||||||||||
Credit contracts |
– |
( |
) |
– |
– |
– |
( |
) | ||||||||||||||||||||||||
Commodity contracts |
( |
) |
– |
– |
– |
– |
( |
) | ||||||||||||||||||||||||
Derivative financial instruments – liabilities |
||||||||||||||||||||||||||||||||
Interest rate contracts |
( |
) |
– |
– |
( |
) |
( |
) |
– |
|||||||||||||||||||||||
Equity contracts |
( |
) |
( |
) |
– |
( |
) |
( |
) |
( |
) (2) | |||||||||||||||||||||
Credit contracts |
– |
– |
( |
) |
– |
– |
( |
) |
||||||||||||||||||||||||
Commodity contracts |
( |
) |
– |
– |
– |
– |
( |
) |
||||||||||||||||||||||||
( |
) |
– |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||
Obligations related to securities sold short |
( |
) |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||
Total |
$ |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
(1) | These amounts represent the gains and losses from fair value changes of Level 3 instruments still held at the end of the period that are recorded in the Consolidated Statement of Income. |
(2) | Certain unrealized gains and losses on derivative assets and liabilities are largely offset by mark-to-market |
As at October 31, 2022 |
||||||||||||||||||||||||||||
($ millions) | Fair value November 1 2021 |
Gains/(losses) recorded in income (1) |
Gains/(losses) recorded in OCI |
Purchases/ Issuances |
Sales/ Settlements |
Transfers into/out of Level 3 |
Fair value October 31 2022 |
|||||||||||||||||||||
Trading assets |
$ | $ | ( |
) | $ | – | $ | $ | ( |
) | $ | $ | ||||||||||||||||
Investment securities |
|
|
( |
) | |
( |
) | ( |
) | |
||||||||||||||||||
Derivative financial instruments |
( |
) | – | – | ||||||||||||||||||||||||
Financial liabilities designated at fair value through profit or loss |
( |
) | – | ( |
) | – | ||||||||||||||||||||||
Obligations related to securities sold short |
– | – | – | ( |
) | ( |
) | ( |
) |
(1) | Gains or losses for items in Level 3 may be offset with losses or gains on related hedges in Level 1 or Level 2. |
• | Trading assets of $ |
• | Trading assets of $ |
• | Trading assets of $ |
• | Trading assets of $ |
• | Investment in equity securities of $million were transferred out of Level 3 into Level 2. |
• | Investments in other foreign governments’ debt of $ |
Valuation technique |
Significant unobservable inputs |
Range of estimates for unobservable inputs (1) |
Changes in fair value from reasonably possible alternatives ($ millions) |
|||||||||||||||||||
Investment securities |
||||||||||||||||||||||
Private equity securities (2) |
||||||||||||||||||||||
per net asset value | - 97% |
|||||||||||||||||||||
multiples |
% - 5% |
65 |
||||||||||||||||||||
Derivative financial instruments |
||||||||||||||||||||||
Interest rate contracts |
pricing | – |
||||||||||||||||||||
model | volatility | |||||||||||||||||||||
Equity contracts |
ng | |||||||||||||||||||||
model | ||||||||||||||||||||||
Commodity contracts |
(1) | The range of estimates represents the actual lowest and highest level inputs used to fair value financial instruments within each financial statement category. |
(2) | The valuation of private equity securities utilizes net asset values as reported by fund managers. Net asset values are not considered observable as the Bank cannot redeem these instruments at such values. The range for net asset values per unit or price per share has not been disclosed for these instruments since the valuations are not model-based. |
8 |
Trading Assets |
(a) |
Trading securities |
As at October 31, 2023 ($ millions) | Remaining term to maturity |
|||||||||||||||||||||||||||
Within three months |
Three to twelve months |
One to five years |
Five to ten years |
Over ten years |
No specific maturity |
Carrying value |
||||||||||||||||||||||
Trading securities: |
||||||||||||||||||||||||||||
Canadian federal government issued or guaranteed debt |
$ |
$ |
$ |
$ |
$ |
$ |
– |
$ |
||||||||||||||||||||
Canadian provincial and municipal debt |
– |
|||||||||||||||||||||||||||
U.S. treasury and other U.S. agency debt |
– |
|||||||||||||||||||||||||||
Other foreign government debt |
– |
|||||||||||||||||||||||||||
Common shares |
– |
– |
– |
– |
– |
|||||||||||||||||||||||
Other |
||||||||||||||||||||||||||||
Total |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||
Total by currency (in Canadian equivalent): |
||||||||||||||||||||||||||||
Canadian dollar |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||
U.S. dollar |
||||||||||||||||||||||||||||
Mexican peso |
||||||||||||||||||||||||||||
Other currencies |
||||||||||||||||||||||||||||
Total trading securities |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||
As at October 31, 2022 ($ millions) | Remaining term to maturity |
|||||||||||||||||||||||||||
Within three months |
Three to twelve months |
One to five years |
Five to ten years |
Over ten years |
No specific maturity |
Carrying value |
||||||||||||||||||||||
Trading securities: |
||||||||||||||||||||||||||||
Canadian federal government issued or guaranteed debt |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
Canadian provincial and municipal debt |
– | |||||||||||||||||||||||||||
U.S. treasury and other U.S. agency debt |
– | |||||||||||||||||||||||||||
Other foreign government debt |
– | |||||||||||||||||||||||||||
Common shares |
– | – | – | – | – | |||||||||||||||||||||||
Other |
||||||||||||||||||||||||||||
Total |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||||||
Total by currency (in Canadian equivalent): |
||||||||||||||||||||||||||||
Canadian dollar |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
U.S. dollar |
||||||||||||||||||||||||||||
Mexican peso |
||||||||||||||||||||||||||||
Other currencies |
||||||||||||||||||||||||||||
Total trading securities |
$ | $ | $ | $ | $ | $ | $ |
(b) |
Trading loans |
As at October 31 ($ millions) | 2023 |
2022 |
||||||
Trading loans (1)(2) |
||||||||
U.S. (3) |
$ |
$ | ||||||
Europe (4) |
||||||||
Canada (4) |
||||||||
Other (4) |
||||||||
Total |
$ |
$ | |
(1) | Geographic segmentation of trading loans is based upon the location of the ultimate risk of the underlying asset. |
(2) | Loans are primarily denominated in U.S. dollars. |
(3) | Includes trading loans that serve as a hedge to loan-based credit total return swaps of $ |
(4) | These loans are primarily related to short-term precious metals trading and lending activities. |
9 |
Financial Instruments Designated at Fair Value Through Profit or Loss |
Fair value |
Change in fair value (1) Gains/(Losses) |
Cumulative change in FV (2) Gains/(Losses) |
||||||||||||||||||||||
As at |
For the year ended |
|||||||||||||||||||||||
October 31 ($ millions) |
2023 |
2022 |
2023 |
2022 |
2023 |
2022 |
||||||||||||||||||
Liabilities |
||||||||||||||||||||||||
Senior note liabilities (3) |
$ |
$ | |
$ |
$ | |
$ |
$ | |
(1) |
Change in the difference between the contractual maturity amount and the carrying value. |
(2) |
The cumulative change in fair value is measured from the instruments’ date of initial recognition. |
(3) |
Changes in fair value attributable to changes in the Bank’s own credit risk are recorded in other comprehensive income. Other changes in fair value are recorded in non-interest income – trading revenues. The offsetting fair value changes from associated derivatives is also recorded in non-interest income – trading revenues. |
Senior Note Liabilities |
||||||||||||||||||||
($ millions) |
Contractual maturity amount |
Carrying Value |
Difference between contractual maturity amount and carrying value |
Changes in fair value for the period attributable to changes in own credit risk recorded in other comprehensive income Gains/(Losses) |
Cumulative changes in fair value attributable to changes in own credit risk (1) Gains/(Losses) |
|||||||||||||||
As at October 31, 2023 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||
As at October 31, 2022 |
$ | |
$ | |
$ | |
$ | |
$ | |
(1) | The cumulative change in fair value is measured from the instruments’ date of initial recognition. |
10 |
Derivative Financial Instruments |
(a) |
Notional amounts (1) |
2023 |
2022 |
|||||||||||||||||||||||
As at October 31 ($ millions) |
Trading |
Hedging |
Total |
Trading |
Hedging |
Total |
||||||||||||||||||
Interest rate contracts |
||||||||||||||||||||||||
Exchange-traded: |
||||||||||||||||||||||||
Futures |
$ |
$ |
– |
$ |
$ |
$ |
– |
$ |
||||||||||||||||
Options purchased |
– |
– |
– |
– |
||||||||||||||||||||
Options written |
– |
– |
– |
– |
||||||||||||||||||||
– |
– |
|||||||||||||||||||||||
Over-the-counter: |
||||||||||||||||||||||||
Forward rate agreements |
– |
– |
– |
– |
||||||||||||||||||||
Swaps |
||||||||||||||||||||||||
Options purchased |
– |
– |
||||||||||||||||||||||
Options written |
– |
– |
||||||||||||||||||||||
Over-the-counter |
||||||||||||||||||||||||
Forward rate agreements |
– |
– |
||||||||||||||||||||||
Swaps |
||||||||||||||||||||||||
Options purchased |
– |
– |
– |
– |
– |
– |
||||||||||||||||||
Options written |
– |
– |
– |
– |
– |
– |
||||||||||||||||||
Total |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||
Foreign exchange and gold contracts |
||||||||||||||||||||||||
Exchange-traded: |
||||||||||||||||||||||||
Futures |
$ |
$ |
– |
$ |
$ |
$ |
– |
$ |
||||||||||||||||
Options purchased |
– |
– |
– |
– |
– |
– |
||||||||||||||||||
Options written |
– |
– |
– |
– |
– |
– |
||||||||||||||||||
– |
– |
|||||||||||||||||||||||
Over-the-counter: |
||||||||||||||||||||||||
Spot and forwards |
||||||||||||||||||||||||
Swaps |
||||||||||||||||||||||||
Options purchased |
– |
– |
||||||||||||||||||||||
Options written |
– |
– |
||||||||||||||||||||||
Over-the-counter |
||||||||||||||||||||||||
Spot and forwards |
– |
– |
||||||||||||||||||||||
Swaps |
– |
– |
– |
– |
– |
– |
||||||||||||||||||
Options purchased |
– |
– |
– |
– |
– |
– |
||||||||||||||||||
Options written |
– |
– |
– |
– |
– |
– |
||||||||||||||||||
– |
– |
|||||||||||||||||||||||
Total |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||
Other derivative contracts |
||||||||||||||||||||||||
Exchange-traded: |
||||||||||||||||||||||||
Equity |
$ |
$ |
– |
$ |
$ |
$ |
– |
$ |
||||||||||||||||
Credit |
– |
– |
– |
– |
– |
– |
||||||||||||||||||
Commodity and other contracts |
– |
– |
||||||||||||||||||||||
– |
– |
|||||||||||||||||||||||
Over-the-counter: |
||||||||||||||||||||||||
Equity |
||||||||||||||||||||||||
Credit |
– |
– |
||||||||||||||||||||||
Commodity and other contracts |
– |
– |
||||||||||||||||||||||
Over-the-counter |
||||||||||||||||||||||||
Equity |
– |
– |
– |
– |
– |
– |
||||||||||||||||||
Credit |
– |
– |
||||||||||||||||||||||
Commodity and other contracts |
– |
– |
||||||||||||||||||||||
– |
– |
|||||||||||||||||||||||
Total |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||
Total notional amounts outstanding |
$ |
$ |
$ |
$ |
$ |
$ |
(1) | The notional amounts represent the amount to which a rate or price is applied to determine the amount of cash flows to be exchanged. |
(b) |
Remaining term to maturity |
As at October 31, 2023 ($ millions) | Within one year |
One to five years |
Over five years |
Total |
||||||||||||
Interest rate contracts |
||||||||||||||||
Futures |
$ |
$ |
$ |
$ |
||||||||||||
Forward rate agreements |
– |
|||||||||||||||
Swaps |
||||||||||||||||
Options purchased |
||||||||||||||||
Options written |
||||||||||||||||
Foreign exchange and gold contracts |
||||||||||||||||
Futures |
||||||||||||||||
Spot and forwards |
||||||||||||||||
Swaps |
||||||||||||||||
Options purchased |
||||||||||||||||
Options written |
||||||||||||||||
Other derivative contracts |
||||||||||||||||
Equity |
||||||||||||||||
Credit |
||||||||||||||||
Commodity and other contracts |
||||||||||||||||
Total |
$ |
$ |
$ |
$ |
||||||||||||
As at October 31, 2022 ($ millions) | Within one year |
One to five years |
Over five years |
Total |
||||||||||||
Interest rate contracts |
||||||||||||||||
Futures |
$ | $ | $ | – | $ | |||||||||||
Forward rate agreements |
||||||||||||||||
Swaps |
||||||||||||||||
Options purchased |
||||||||||||||||
Options written |
||||||||||||||||
Foreign exchange and gold contracts |
||||||||||||||||
Futures |
||||||||||||||||
Spot and forwards |
||||||||||||||||
Swaps |
||||||||||||||||
Options purchased |
||||||||||||||||
Options written |
||||||||||||||||
Other derivative contracts |
||||||||||||||||
Equity |
||||||||||||||||
Credit |
||||||||||||||||
Commodity and other contracts |
||||||||||||||||
Total |
$ | |
$ | |
$ | |
$ | |
(c) |
Credit risk |
2023 |
2022 |
|||||||||||||||||||||||||||||||||
Revised Basel III (1) |
Basel III |
|||||||||||||||||||||||||||||||||
As at October 31 ($ millions) |
Notional amount |
Credit risk amount (CRA) (2) |
Credit equivalent amount (CEA) (2) |
Risk- Weighted Assets |
Notional amount |
Credit risk amount (CRA) (2) |
Credit equivalent amount (CEA) (2) |
Risk- Weighted Assets |
||||||||||||||||||||||||||
Interest rate contracts |
||||||||||||||||||||||||||||||||||
Futures |
$ |
$ |
– |
$ |
$ |
$ |
$ |
– |
$ |
$ |
– |
|||||||||||||||||||||||
Forward rate agreements |
||||||||||||||||||||||||||||||||||
Swaps |
||||||||||||||||||||||||||||||||||
Options purchased |
||||||||||||||||||||||||||||||||||
Options written |
– |
– |
||||||||||||||||||||||||||||||||
Foreign exchange and gold contracts |
||||||||||||||||||||||||||||||||||
Futures |
– |
– |
||||||||||||||||||||||||||||||||
Spot and forwards |
||||||||||||||||||||||||||||||||||
Swaps |
||||||||||||||||||||||||||||||||||
Options purchased |
||||||||||||||||||||||||||||||||||
Options written |
– |
– |
||||||||||||||||||||||||||||||||
Other derivative contracts |
||||||||||||||||||||||||||||||||||
Equity |
||||||||||||||||||||||||||||||||||
Credit |
||||||||||||||||||||||||||||||||||
Commodity and other contracts |
||||||||||||||||||||||||||||||||||
Credit Valuation Adjustment |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||
Total derivatives |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||||
Amount settled through central counterparties (3) |
||||||||||||||||||||||||||||||||||
Exchange-traded |
– |
– |
||||||||||||||||||||||||||||||||
Over-the-counter |
– |
– |
||||||||||||||||||||||||||||||||
$ |
$ |
– |
$ |
$ |
$ |
$ |
– |
$ |
$ |
(1) |
Regulatory amounts reported in 2023 are under Revised Basel III requirements and are not directly comparable to amounts reported in 2022. |
(2) |
The amounts presented are net of collateral and master netting agreements at the product level. The total amounts relating to netting and collateral were $ |
(3) |
Amounts are included under total derivatives above. Amounts include exposures settled directly through central counterparties and exposures settled through clearing members of central counterparties. |
1 |
Regulatory haircuts prescribed by the OSFI CAR Guidelines are applied to the collateral balances of the CRA measure. |
(d) |
Fair value |
As at October 31 ($ millions) |
2023 |
2023 |
2022 |
|||||||||||||||||||||||||
Average fair value |
Year-end fair value |
Year-end fair value(1) |
||||||||||||||||||||||||||
Favourable |
Unfavourable |
Favourable |
Unfavourable |
Favourable |
Unfavourable |
|||||||||||||||||||||||
Trading |
||||||||||||||||||||||||||||
Interest rate contracts |
||||||||||||||||||||||||||||
Forward rate agreements |
$ |
$ |
$ |
$ |
– |
$ | $ | |||||||||||||||||||||
Swaps |
||||||||||||||||||||||||||||
Options |
||||||||||||||||||||||||||||
Foreign exchange and gold contracts |
||||||||||||||||||||||||||||
Forwards |
||||||||||||||||||||||||||||
Swaps |
||||||||||||||||||||||||||||
Options |
||||||||||||||||||||||||||||
Other derivative contracts |
||||||||||||||||||||||||||||
Equity |
||||||||||||||||||||||||||||
Credit |
||||||||||||||||||||||||||||
Commodity and other contracts |
||||||||||||||||||||||||||||
Trading derivatives’ market valuation |
$ |
$ |
$ |
$ |
$ | $ | ||||||||||||||||||||||
Hedging |
||||||||||||||||||||||||||||
Interest rate contracts |
||||||||||||||||||||||||||||
Swaps |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||
Foreign exchange and gold contracts |
||||||||||||||||||||||||||||
Forwards |
||||||||||||||||||||||||||||
Swaps |
||||||||||||||||||||||||||||
$ |
$ |
$ |
$ |
|||||||||||||||||||||||||
Other derivative contracts |
||||||||||||||||||||||||||||
Equity |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||
Hedging derivatives’ market valuation |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||
Total derivative financial instruments as per Statement of Financial Position |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||
Less: impact of master netting and collateral (2) |
||||||||||||||||||||||||||||
Net derivative financial instruments (2) |
$ |
$ |
$ |
|
$ |
|
(1) | The average fair value of trading derivatives’ market valuation for the year ended October 31, 2022 was: favourable $ month-end balances. |
(2) | Master netting agreement amounts are based on the capital adequacy criteria of the Basel Committee on Banking Supervision (BCBS) and OSFI. These criteria allow netting where there are legally enforceable contracts which enable net settlement in the event of a default, bankruptcy, liquidation or similar circumstances. |
(e) |
Hedging activities |
• | The use of different discount curves to value the hedged item and the hedging derivative in fair value hedges, in order to reflect the reduced credit risk of collateralized derivatives; |
• | Differences in key terms such as the underlying reference interest rate tenor, reset/settlement frequency and floating spread between the hedging instruments and the hedged item. |
2023 |
2022 |
|||||||||||||||||||||||||||||||
Notional amounts (1) |
Notional amounts (1) |
|||||||||||||||||||||||||||||||
Remaining term to maturity |
Remaining term to maturity |
|||||||||||||||||||||||||||||||
As at October 31 ($ millions) | Within one year |
One to five years |
Over five years |
Total |
Within one year |
One to five years |
Over five years |
Total |
||||||||||||||||||||||||
Fair value hedges |
||||||||||||||||||||||||||||||||
Interest rate risk – swaps |
$ |
$ |
$ |
$ |
$ | $ | $ | $ | ||||||||||||||||||||||||
Foreign currency/interest rate risk – swaps |
– |
– |
– |
– |
– | – | – | – | ||||||||||||||||||||||||
Cash flow hedges |
||||||||||||||||||||||||||||||||
Interest rate risk – swaps |
||||||||||||||||||||||||||||||||
Foreign currency/interest rate risk – swaps |
||||||||||||||||||||||||||||||||
Foreign currency risk |
||||||||||||||||||||||||||||||||
Swaps |
||||||||||||||||||||||||||||||||
Foreign currency forwards |
– |
– |
– | – | ||||||||||||||||||||||||||||
Cash |
– |
– |
– | – | ||||||||||||||||||||||||||||
Equity risk – total return swaps |
– |
– | ||||||||||||||||||||||||||||||
Net investment hedges |
||||||||||||||||||||||||||||||||
Foreign currency risk |
||||||||||||||||||||||||||||||||
Foreign currency forwards |
– |
– |
– | – | ||||||||||||||||||||||||||||
Deposit liabilities |
– |
– |
– | – | ||||||||||||||||||||||||||||
Total |
$ |
$ |
$ |
$ |
$ | |
$ | |
$ | |
$ | |
(1) | Notional amounts relating to derivatives that are hedging multiple risks in both assets and liabilities are included in more than one category. |
2023 |
2022 |
|||||||||||||||||||||||
Average rate or price (1) |
Average rate or price (1) |
|||||||||||||||||||||||
As at October 31 |
Fixed interest rate |
FX rate |
Price |
Fixed interest rate |
FX rate |
Price |
||||||||||||||||||
Fair value hedges |
||||||||||||||||||||||||
Interest rate risk – swaps |
% |
n/a |
n/a |
% | n/a | n/a | ||||||||||||||||||
Cash flow hedges |
||||||||||||||||||||||||
Interest rate risk – swaps |
% |
n/a |
n/a |
% | n/a | n/a | ||||||||||||||||||
Foreign currency/interest rate risk – swaps |
||||||||||||||||||||||||
CAD-USD |
% |
n/a |
% | n/a | ||||||||||||||||||||
Foreign currency risk |
||||||||||||||||||||||||
Swaps |
||||||||||||||||||||||||
CAD-USD |
n/a |
n/a |
n/a | n/a | ||||||||||||||||||||
CAD-EUR |
n/a |
n/a |
n/a | n/a | ||||||||||||||||||||
CAD-GBP |
n/a |
n/a |
n/a | n/a | ||||||||||||||||||||
Foreign currency forwards |
||||||||||||||||||||||||
CAD-USD |
n/a |
n/a |
n/a |
n/a | n/a | |||||||||||||||||||
Equity price risk – total return swaps |
n/a |
n/a |
$ |
n/a | n/a | $ | |
|||||||||||||||||
Net investment hedges |
||||||||||||||||||||||||
Foreign currency risk – foreign currency forwards |
||||||||||||||||||||||||
CAD-USD |
n/a |
n/a |
n/a | n/a | ||||||||||||||||||||
MXN-CAD |
n/a |
n/a |
n/a | n/a | ||||||||||||||||||||
PEN-CAD |
n/a |
n/a |
n/a | n/a |
(1) | The average rate or price is calculated in aggregate for all of the Bank’s hedge relationships, including hedges of assets and liabilities. The majority of the Bank’s hedges have a remaining term to maturity of less than |
Carrying amount of the hedging instruments (1) |
Hedge Ineffectiveness (2) |
Accumulated amount of fair value hedge adjustment gains/ (losses) on the hedged item (4) |
||||||||||||||||||||||||||||||||||
For the year ended October 31, 2023 ($ millions) |
Assets |
Liabilities |
Gains/(losses) on hedging instrument used to calculate hedge ineffectiveness |
Gains/ (losses) on hedged item used to calculate hedge ineffectiveness |
Ineffectiveness recorded in non-interest income – other |
Carrying amount of the hedged item (3) |
Active hedges |
Discontinued hedges |
||||||||||||||||||||||||||||
Fair value hedges |
||||||||||||||||||||||||||||||||||||
Interest rate risk – swaps |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
( |
) |
|||||||||||||||||||||||||
Investment securities |
( |
) |
( |
) |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||||||||||
Loans |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||||||||
Deposit liabilities |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
Subordinated debentures |
( |
) |
– |
( |
) |
( |
) | |||||||||||||||||||||||||||||
Foreign currency/interest |
||||||||||||||||||||||||||||||||||||
rate risk – swaps |
– |
– |
– |
– |
– |
|||||||||||||||||||||||||||||||
Investment securities |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||
Total |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
$ |
( |
) |
(1) | Comprises unrealized gains/losses and are recorded within derivative financial instruments in assets and liabilities, respectively in the Consolidated Statement of Financial Position. |
(2) | Includes ineffectiveness related to hedges discontinued during the year ended October 31, 2023. |
(3) | This represents the carrying value on the Consolidated Statement of Financial Position and comprises amortized cost before allowance for credit losses, plus fair value hedge adjustment, except for investment securities which are carried at fair value. |
(4) | This represents the accumulated fair value hedge adjustment and is a component of the carrying amount of the hedged item. |
Carrying amount of the hedging instruments (1) |
Hedge Ineffectiveness (2) |
Accumulated amount of fair value hedge adjustment gains/ (losses) on the hedged item (4) |
||||||||||||||||||||||||||||||||||
For the year ended October 31, 2022 ($ millions) |
Assets |
Liabilities |
Gains/(losses) on hedging instrument used to calculate hedge ineffectiveness |
Gains/ (losses) on hedged item used to calculate hedge ineffectiveness |
Ineffectiveness recorded in non-interest income – other |
Carrying amount of the hedged item (3) |
Active hedges |
Discontinued hedges |
||||||||||||||||||||||||||||
Fair value hedges |
||||||||||||||||||||||||||||||||||||
Interest rate risk – swaps |
$ | |
$ | ( |
) | $ | $ | ( |
) | $ | ||||||||||||||||||||||||||
Investment securities |
( |
) | $ | $ | ( |
) | $ | |||||||||||||||||||||||||||||
Loans |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||
Deposit liabilities |
( |
) | ( |
) | |
|||||||||||||||||||||||||||||||
Subordinated debentures |
( |
) | – | ( |
) | ( |
) | |||||||||||||||||||||||||||||
Foreign currency/interest |
||||||||||||||||||||||||||||||||||||
rate risk – swaps |
– | – | – | – | – | |||||||||||||||||||||||||||||||
Investment securities |
– | – | – | – | ( |
) | ||||||||||||||||||||||||||||||
Total |
$ | $ | ( |
) | $ | |
$ | ( |
) | $ | |
$ | |
$ | $ | ( |
) |
(1) | Comprises unrealized gains/losses and are recorded within derivative financial instruments in assets and liabilities, respectively in the Consolidated Statement of Financial Position. |
(2) | Includes ineffectiveness related to hedges discontinued during the year ended October 31, 2022. |
(3) | This represents the carrying value on the Consolidated Statement of Financial Position and comprises amortized cost before allowance for credit losses, plus fair value hedge adjustment, except for investment securities which are carried at fair value. |
(4) | This represents the accumulated fair value hedge adjustment and is a component of the carrying amount of the hedged item. |
Carrying amount of the hedging instruments (1) |
Hedge Ineffectiveness (2) |
|||||||||||||||||||||||
For the year ended October 31, 2023 ($ millions) |
Assets |
Liabilities |
Gains/(losses) on hedging instrument used to calculate hedge ineffectiveness |
Gains/(losses) on hypothetical derivative used to calculate hedge ineffectiveness (3) |
Ineffectiveness recorded in non-interest income – other (4) |
|||||||||||||||||||
Cash flow hedges |
||||||||||||||||||||||||
Interest rate risk – swaps |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
|||||||||||||
Foreign currency/interest rate risk – swaps |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||||
Foreign currency risk |
||||||||||||||||||||||||
Swaps |
( |
) |
( |
) | ||||||||||||||||||||
Foreign currency forwards |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||||
Cash |
– |
( |
) |
( |
) |
– |
||||||||||||||||||
Equity risk – total return swaps |
( |
) |
( |
) |
( |
) |
– |
|||||||||||||||||
( |
) |
|||||||||||||||||||||||
Net investment hedges |
||||||||||||||||||||||||
Foreign currency risk |
||||||||||||||||||||||||
Foreign currency forwards |
( |
) |
( |
) |
( |
) |
– |
|||||||||||||||||
Deposit liabilities |
n/a |
( |
) |
( |
) |
( |
) |
– |
||||||||||||||||
( |
) |
( |
) |
( |
) |
– |
||||||||||||||||||
Total |
$ |
$ |
( |
) |
$ |
$ |
$ |
(1) | Comprises unrealized gains/losses for derivative instruments and are recorded within derivative financial instruments in assets and liabilities, respectively in the Consolidated Statement of Financial Position. |
(2) | Includes ineffectiveness related to hedges discontinued during the year ended October 31, 2023. |
(3) | For cash flow hedges, hypothetical derivatives having critical terms which match those of the underlying hedged item are used to assess hedge ineffectiveness. |
(4) | For cash flow hedges, ineffectiveness is only recognized in the Consolidated Statement of Income when the life-to-date |
Carrying amount of the hedging instruments (1) |
Hedge Ineffectiveness (2) |
|||||||||||||||||||||||
For the year ended October 31, 2022 ($ millions) | Assets |
Liabilities |
Gains/(losses) on hedging instrument used to calculate hedge ineffectiveness |
Gains/(losses) on hypothetical derivative used to calculate hedge ineffectiveness (3) |
Ineffectiveness recorded in non-interest income – other (4) |
|||||||||||||||||||
Cash flow hedges |
||||||||||||||||||||||||
Interest rate risk – swaps |
$ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | |||||||||||||
Foreign currency/interest rate risk – swaps |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Foreign currency risk |
||||||||||||||||||||||||
Swaps |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Foreign currency forwards |
( |
) | ||||||||||||||||||||||
Cash |
– | – | ||||||||||||||||||||||
Equity risk – total return swaps |
( |
) | ( |
) | ( |
) | – | |||||||||||||||||
( |
) | ( |
) | ( |
) | ( |
) | |||||||||||||||||
Net investment hedges |
||||||||||||||||||||||||
Foreign currency risk |
||||||||||||||||||||||||
Foreign currency forwards |
( |
) | ( |
) | ( |
) | – | |||||||||||||||||
Deposit liabilities |
n/a | ( |
) | ( |
) | ( |
) | – | ||||||||||||||||
( |
) | ( |
) | ( |
) | – | ||||||||||||||||||
Total |
$ | |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) |
(1) | Comprises unrealized gains/losses for derivative instruments and are recorded within derivative financial instruments in assets and liabilities, respectively in the Consolidated Statement of Financial Position. |
(2) | Includes ineffectiveness related to hedges discontinued during the year ended October 31, 2022. |
(3) | For cash flow hedges, hypothetical derivatives having critical terms which match those of the underlying hedged item are used to assess hedge ineffectiveness. |
(4) | For cash flow hedges, ineffectiveness is only recognized in the Consolidated Statement of Income when the life-to-date |
AOCI gains/ (losses) as at November 1, 2022 |
Net gains/ (losses) recognized in OCI |
Amount reclassified to net income as the hedged item affects net income (1) |
AOCI gains/ (losses) as at October 31, 2023 |
Balance in cash flow hedge reserve/unrealized foreign currency translation account as at October 31, 2023 |
||||||||||||||||||||
For the year ended October 31, 2023 ($ millions) |
Active hedges |
Discontinued hedges |
||||||||||||||||||||||
Cash flow hedges |
||||||||||||||||||||||||
Interest rate risk |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | ||||||||
Foreign currency/interest rate risk |
( |
) |
( |
) |
( |
) |
( |
) |
||||||||||||||||
Foreign currency risk |
( |
) |
( |
) |
( |
) |
( |
) |
||||||||||||||||
Equity risk |
( |
) |
( |
) |
( |
) |
( |
) |
||||||||||||||||
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | |||||||||||||||
Net investment hedges |
||||||||||||||||||||||||
Foreign currency risk |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||
Total |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
(1) | Amounts reclassified from the cash flow hedge and net investment hedge reserves to net income are recorded in non-interest income-other except for amortization, which is recorded in interest income. |
AOCI gains/ (losses) as at November 1, 2021 |
Net gains/ (losses) recognized in OCI |
Amount reclassified to net income as the hedged item affects net income (1) |
AOCI gains/ (losses) as at October 31, 2022 |
Balance in cash flow hedge reserve/unrealized foreign currency translation account as at October 31, 2022 |
||||||||||||||||||||
For the year ended October 31, 2022 ($ millions) |
Active hedges |
Discontinued hedges |
||||||||||||||||||||||
Cash flow hedges |
||||||||||||||||||||||||
Interest rate risk |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
||||||||||
Foreign currency/interest rate risk |
( |
) |
( |
) |
( |
) |
( |
) |
||||||||||||||||
Foreign currency risk |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||||
Equity risk |
( |
) |
( |
) |
( |
) |
– |
|||||||||||||||||
( |
) |
( |
) |
( |
) |
( |
) |
|||||||||||||||||
Net investment hedges |
||||||||||||||||||||||||
Foreign currency risk |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||
Total |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
(1) | Amounts reclassified from the cash flow hedge and net investment hedge reserves to net income are recorded in non-interest income-other. |
11 |
Offsetting Financial Assets and Financial Liabilities |
As at October 31, 2023 ($ millions) |
||||||||||||||||||||||||
Types of financial assets |
Gross amounts of recognized financial instruments |
Gross amounts of recognized financial instruments offset in the Consolidated Statement of Financial Position |
Net amounts of financial instruments presented in the Consolidated Statement of Financial Position |
Related amounts not offset in the Consolidated Statement of Financial Position |
||||||||||||||||||||
Impact of master netting arrangements or similar agreements (1) |
Collateral (2)(4) |
Net amount (3) |
||||||||||||||||||||||
Derivative financial instruments |
$ |
$ |
– |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
|||||||||||||
Securities purchased under resale agreements and securities borrowed |
( |
) |
( |
) |
( |
) |
||||||||||||||||||
Total |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
||||||||||||
Types of financial liabilities | ||||||||||||||||||||||||
Derivative financial instruments |
$ |
$ |
– |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
|||||||||||||
Obligations related to securities sold under repurchase agreements and securities lent |
( |
) |
( |
) |
( |
) |
||||||||||||||||||
Total |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
||||||||||||
As at October 31, 2022 ($ millions) | ||||||||||||||||||||||||
Types of financial assets | Gross amounts of recognized financial instruments |
Gross amounts of recognized financial instruments offset in the Consolidated Statement of Financial Position |
Net amounts of financial instruments presented in the Consolidated Statement of Financial Position |
Related amounts not offset in the Consolidated statement of Financial Position |
Net amount (3) |
|||||||||||||||||||
Impact of master netting arrangements or similar agreements (1) |
Collateral (2)(4) |
|||||||||||||||||||||||
Derivative financial instruments |
$ | $ | ( |
) | $ | $ | ( |
) | $ | ( |
) | $ | ||||||||||||
Securities purchased under resale agreements and securities borrowed |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
Total |
$ | $ | ( |
) | $ | $ | ( |
) | $ | ( |
) | $ | ||||||||||||
Types of financial liabilities | ||||||||||||||||||||||||
Derivative financial instruments |
$ | $ | ( |
) | $ | $ | ( |
) | $ | ( |
) | $ | ||||||||||||
Obligations related to securities sold under repurchase agreements and securities lent |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
Total |
$ | |
$ | ( |
) | $ | |
$ | ( |
) | $ | ( |
) | $ | |
(1) | Amounts that are subject to master netting arrangements or similar agreements but were not offset in the Consolidated Statement of Financial Position because they did not meet the net settlement/simultaneous settlement criteria; or because the rights of set off are conditional upon the default of the counterparty only. |
(2) | Cash and financial instrument collateral amounts received or pledged in relation to the total amounts of financial assets and financial liabilities, including those that were not offset in the Consolidated Statement of Financial Position. These amounts are disclosed at fair value and the rights of set off are conditional upon the default of the counterparty. |
(3) | Not intended to represent the Bank’s actual exposure to credit risk, as a variety of credit mitigation strategies are employed in addition to offsetting and collateral arrangements. |
(4) | Derivative financial instruments assets include cash collateral of $ $ million) and non-cash collateral of $ million). Derivative financial instruments liabilities include cash collateral of $ million) and non-cash collateral of $ million). |
12 |
Investment Securities |
As at October 31 ($ millions) | 2023 |
2022 |
||||||
Debt investment securities measured at FVOCI |
$ |
$ | ||||||
Debt investment securities measured at amortized cost |
||||||||
Equity investment securities designated at FVOCI |
||||||||
Equity investment securities measured at FVTPL |
||||||||
Debt investment securities measured at FVTPL |
||||||||
Total investment securities |
$ |
$ | |
(a) |
Debt investment securities measured at fair value through other comprehensive income (FVOCI) |
2023 |
2022 |
|||||||||||||||||||||||||||||||
As at October 31 ($ millions) |
Cost |
Gross unrealized gains |
Gross unrealized losses |
Fair value |
Cost |
Gross unrealized gains |
Gross unrealized losses |
Fair value |
||||||||||||||||||||||||
Canadian federal government issued or guaranteed debt |
$ |
$ |
$ |
$ |
$ | $ | $ | $ | ||||||||||||||||||||||||
Canadian provincial and municipal debt |
||||||||||||||||||||||||||||||||
U.S. treasury and other U.S. agency debt |
||||||||||||||||||||||||||||||||
Other foreign government debt |
||||||||||||||||||||||||||||||||
Other debt |
||||||||||||||||||||||||||||||||
Total |
$ |
$ |
$ |
$ |
$ | |
$ | |
$ | |
$ | |
(b) |
Debt investment securities measured at amortized cost |
2023 |
2022 |
|||||||||||||||
As at October 31 ($ millions) | Fair Value |
Carrying value (1) |
Fair Value |
Carrying value (1) |
||||||||||||
Canadian federal and provincial government issued or guaranteed debt |
$ |
$ |
$ | $ | ||||||||||||
U.S. treasury and other U.S. agency debt |
||||||||||||||||
Other foreign government debt |
||||||||||||||||
Corporate debt |
||||||||||||||||
Total |
$ |
$ |
$ | |
$ | |
(1) | Balances are net of allowances of $ |
(c) |
Equity investment securities designated at fair value through other comprehensive income (FVOCI) |
As at October 31, 2023 ($ millions) | Cost |
Gross unrealized gains |
Gross unrealized losses |
Fair value |
||||||||||||
Preferred equity instruments |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
||||||||
Common shares |
||||||||||||||||
Total |
$ |
$ |
$ |
$ |
||||||||||||
As at October 31, 2022 ($ millions) | Cost |
Gross unrealized gains |
Gross unrealized losses |
Fair value |
||||||||||||
Preferred equity instruments |
$ | – | $ | – | $ | – | $ | – | ||||||||
Common shares |
||||||||||||||||
Total |
$ | |
$ | |
$ | |
$ | |
(d) |
An analysis of the carrying value of investment securities is as follows: |
Remaining term to maturity |
||||||||||||||||||||||||||||
As at October 31, 2023 ($ millions) |
Within three months |
Three to twelve months |
One to five years |
Five to ten years |
Over ten years |
No specific maturity |
Carrying value |
|||||||||||||||||||||
Fair value through other comprehensive income |
||||||||||||||||||||||||||||
Debt instruments |
||||||||||||||||||||||||||||
Canadian federal government issued or guaranteed debt |
$ |
$ |
$ |
$ |
$ |
$ |
– |
$ |
||||||||||||||||||||
Yield (1) % |
– |
|||||||||||||||||||||||||||
Canadian provincial and municipal debt |
– |
|||||||||||||||||||||||||||
Yield (1) % |
– |
|||||||||||||||||||||||||||
U.S. treasury and other U.S. agency debt |
– |
|||||||||||||||||||||||||||
Yield (1) % |
– |
|||||||||||||||||||||||||||
Other foreign government debt |
– |
|||||||||||||||||||||||||||
Yield (1) % |
– |
|||||||||||||||||||||||||||
Other debt |
– |
|||||||||||||||||||||||||||
Yield (1) % |
– |
|||||||||||||||||||||||||||
– |
||||||||||||||||||||||||||||
Equity instruments |
||||||||||||||||||||||||||||
Preferred equity instruments |
– |
– |
– |
– |
– |
– |
– |
|||||||||||||||||||||
Common shares |
– |
– |
– |
– |
– |
|||||||||||||||||||||||
Total FVOCI |
||||||||||||||||||||||||||||
Amortized cost |
||||||||||||||||||||||||||||
Canadian federal and provincial government issued or guaranteed debt |
– |
– |
||||||||||||||||||||||||||
Yield (1) % |
– |
– |
||||||||||||||||||||||||||
U.S. treasury and other U.S. agency debt |
– |
– |
||||||||||||||||||||||||||
Yield (1) % |
– |
– |
||||||||||||||||||||||||||
Other foreign government debt |
– |
|||||||||||||||||||||||||||
Yield (1) % |
– |
|||||||||||||||||||||||||||
Corporate debt |
– |
– |
||||||||||||||||||||||||||
Yield (1) % |
– |
– |
||||||||||||||||||||||||||
– |
||||||||||||||||||||||||||||
Fair value through profit or loss |
||||||||||||||||||||||||||||
Equity instruments |
– |
– |
– |
– |
– |
|||||||||||||||||||||||
Debt instruments |
– |
– |
– |
– |
– |
|||||||||||||||||||||||
Total investment securities |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||
Total by currency (in Canadian equivalent): |
||||||||||||||||||||||||||||
Canadian dollar |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||
U.S. dollar |
||||||||||||||||||||||||||||
Mexican peso |
– |
|||||||||||||||||||||||||||
Other currencies |
||||||||||||||||||||||||||||
Total investment securities |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
(1) | Represents the weighted-average yield of fixed income securities. |
Remaining term to maturity |
||||||||||||||||||||||||||||
As at October 31, 2022 ($ millions) | Within three months |
Three to twelve months |
One to five years |
Five to ten years |
Over ten years |
No specific maturity |
Carrying value |
|||||||||||||||||||||
Fair value through other comprehensive income |
||||||||||||||||||||||||||||
Debt instruments |
||||||||||||||||||||||||||||
Canadian federal government issued or guaranteed debt |
$ | $ | $ | $ | $ | $ | – | $ | ||||||||||||||||||||
Yield (1) % |
– | |||||||||||||||||||||||||||
Canadian provincial and municipal debt |
– | – | ||||||||||||||||||||||||||
Yield (1) % |
– |
– | ||||||||||||||||||||||||||
U.S. treasury and other U.S. agency debt |
– | |||||||||||||||||||||||||||
Yield (1) % |
– | |||||||||||||||||||||||||||
Other foreign government debt |
– | |||||||||||||||||||||||||||
Yield (1) % |
– | |||||||||||||||||||||||||||
Other debt |
||||||||||||||||||||||||||||
Yield (1) % |
||||||||||||||||||||||||||||
Equity instruments |
||||||||||||||||||||||||||||
Preferred equity instruments |
– | – | – | – | – | – | – | |||||||||||||||||||||
Common shares |
– | – | – | – | – | |||||||||||||||||||||||
Total FVOCI |
||||||||||||||||||||||||||||
Amortized cost |
||||||||||||||||||||||||||||
Canadian federal and provincial government issued or guaranteed debt |
– | |||||||||||||||||||||||||||
Yield (1) % |
– | |||||||||||||||||||||||||||
U.S. treasury and other U.S. agency debt |
– | – | ||||||||||||||||||||||||||
Yield (1) % |
– |
– | ||||||||||||||||||||||||||
Other foreign government debt |
– | |||||||||||||||||||||||||||
Yield (1) % |
– | |||||||||||||||||||||||||||
Corporate debt |
( |
) | – | – | ||||||||||||||||||||||||
Yield (1) % |
– |
– |
||||||||||||||||||||||||||
– | ||||||||||||||||||||||||||||
Fair value through profit or loss |
||||||||||||||||||||||||||||
Equity instruments |
– | – | – | – | – | |||||||||||||||||||||||
Debt instruments |
– | – | – | – | ||||||||||||||||||||||||
Total investment securities |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
Total by currency (in Canadian equivalent): |
||||||||||||||||||||||||||||
Canadian dollar |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
U.S. dollar |
||||||||||||||||||||||||||||
Mexican peso |
– | |||||||||||||||||||||||||||
Other currencies |
||||||||||||||||||||||||||||
Total investment securities |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
(1) | Represents the weighted-average yield of fixed income securities. |
(e) |
Net gain on sale of investment securities |
For the year ended October 31 ($ millions) | 2023 |
2022 |
||||||
Debt investment securities measured at amortized cost |
$ |
$ | ||||||
Debt investment securities measured at FVOCI |
||||||||
Net gain on sale of investment securities |
$ |
$ | |
13 |
Loans, Impaired Loans and Allowance for Credit Losses |
(a) |
Loans at amortized cost |
2023 |
2022 |
|||||||||||||||||||||||
As at October 31 ($ millions) | Gross loans |
Allowance for credit losses |
Net carrying amount |
Gross loans |
Allowance for credit losses |
Net carrying amount |
||||||||||||||||||
Residential mortgages |
$ |
$ |
$ |
$ | |
$ | $ | |||||||||||||||||
Personal loans |
||||||||||||||||||||||||
Credit cards |
||||||||||||||||||||||||
Business and government |
||||||||||||||||||||||||
Total |
$ |
$ |
$ |
$ | $ | |
$ | |
(b) |
Loans and acceptances outstanding by geography ( 1) |
As at October 31 ($ millions) |
2023 |
2022 |
||||||
Canada: |
||||||||
Residential mortgages |
$ |
$ | ||||||
Personal loans |
||||||||
Credit cards |
||||||||
Business and government |
||||||||
United States: |
||||||||
Personal loans |
||||||||
Business and government |
||||||||
Mexico: |
||||||||
Residential mortgages |
||||||||
Personal loans |
||||||||
Credit cards |
||||||||
Business and government |
||||||||
Chile: |
||||||||
Residential mortgages |
||||||||
Personal loans |
||||||||
Credit cards |
||||||||
Business and government |
||||||||
Peru: |
||||||||
Residential mortgages |
||||||||
Personal loans |
||||||||
Credit cards |
||||||||
Business and government |
||||||||
Colombia: |
||||||||
Residential mortgages |
||||||||
Personal loans |
||||||||
Credit cards |
||||||||
Business and government |
||||||||
Other International: |
||||||||
Residential mortgages |
||||||||
Personal loans |
||||||||
Credit cards |
||||||||
Business and government |
||||||||
Total loans |
||||||||
Acceptances (2) |
||||||||
Total loans and acceptances (3) |
||||||||
Allowance for credit losses |
( |
) |
( |
) | ||||
Total loans and acceptances net of allowance for credit losses |
$ |
$ | |
(1) | Geographic segmentation is based on the location of the property for residential mortgages; otherwise, the residence of the borrower. |
(2) |
(3) | . S. dollars were $ |
(c) |
Loan maturities |
As at October 31, 2023 | Remaining term to maturity |
Rate sensitivity |
||||||||||||||||||||||||||||||||||||||
($ millions) | Within one year |
One to five years |
Five to ten years |
Over ten years |
No specific maturity |
Total |
Floating |
Fixed rate |
Non-rate sensitive |
Total |
||||||||||||||||||||||||||||||
Residential mortgages |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||||||||
Personal loans |
||||||||||||||||||||||||||||||||||||||||
Credit cards |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||
Business and government |
||||||||||||||||||||||||||||||||||||||||
Total |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||||||||
Allowance for credit losses |
– |
– |
– |
– |
( |
) |
( |
) |
– |
– |
( |
) |
( |
) | ||||||||||||||||||||||||||
Total loans net of allowance for credit losses |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
( |
) |
$ |
||||||||||||||||||||||||||||
As at October 31, 2022 | Remaining term to maturity |
Rate sensitivity |
||||||||||||||||||||||||||||||||||||||
($ millions) | Within one year |
One to five years |
Five to ten years |
Over ten years |
No specific maturity |
Total |
Floating |
Fixed rate |
Non-rate sensitive |
Total |
||||||||||||||||||||||||||||||
Residential mortgages |
$ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
Personal loans |
||||||||||||||||||||||||||||||||||||||||
Credit cards |
– | – | – | – | – | – | ||||||||||||||||||||||||||||||||||
Business and government |
||||||||||||||||||||||||||||||||||||||||
Total |
$ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
Allowance for credit losses |
– | – | – | – | ( |
) | ( |
) | – | – | ( |
) | ( |
) | ||||||||||||||||||||||||||
Total loans net of allowance for credit losses |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | ( |
) | $ | |
(d) |
Impaired loans (1) |
2023 |
2022 |
|||||||||||||||||||||||
As at October 31 ($ millions) |
Gross impaired loans (1) |
Allowance for credit losses |
Net |
Gross impaired loans (1) |
Allowance for credit losses |
Net |
||||||||||||||||||
Residential mortgages |
$ |
$ |
$ |
$ | $ | $ | ||||||||||||||||||
Personal loans |
||||||||||||||||||||||||
Credit cards |
– |
– |
– |
– | – | – | ||||||||||||||||||
Business and government |
||||||||||||||||||||||||
Total |
$ |
$ |
$ |
$ | |
$ | |
$ | |
|||||||||||||||
By geography: |
||||||||||||||||||||||||
Canada |
$ |
$ |
$ |
$ | $ | $ | ||||||||||||||||||
United States |
– |
– |
– |
– | – | – | ||||||||||||||||||
Mexico |
||||||||||||||||||||||||
Peru |
||||||||||||||||||||||||
Chile |
||||||||||||||||||||||||
Colombia |
||||||||||||||||||||||||
Other International |
||||||||||||||||||||||||
Total |
$ |
$ |
$ |
$ | $ | $ |
(1) | Interest income recognized on impaired loans during the year ended October 31, 2023 was $ |
(e) |
Allowance for credit losses |
(i) |
Key inputs and assumptions |
• | Changes in risk ratings of the borrower or instrument reflecting changes in their credit quality; |
• | Changes in the volumes of transactions; |
• | Changes in the forward-looking macroeconomic environment reflected in the variables used in the models such as GDP growth, unemployment rates, commodity prices, interest rates and house price indices, which are closely related with credit losses in the relevant portfolio; |
• | Changes in macroeconomic scenarios and the probability weights assigned to each scenario; and |
• | Borrower migration between the three stages. |
(ii) |
Key macroeconomic variables |
Base Case Scenario |
Alternative Scenario – Optimistic |
Alternative Scenario – Pessimistic |
Alternative Scenario – Very Pessimistic |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
October 31, 2023 |
Next 12 Months |
Remaining Forecast Period |
Next 12 Months |
Remaining Forecast Period |
Next 12 Months |
Remaining Forecast Period |
Next 12 Months |
Remaining Forecast Period |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Canada |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real GDP growth, y/y % change |
- |
- |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consumer price index, y/y % |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unemployment rate, average % |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bank of Canada overnight rate target, average % |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
HPI – Housing Price Index, y/y % change |
- |
- |
- |
- |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
USD/CAD exchange rate, average |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
U.S. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real GDP growth, y/y % change |
- |
- |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consumer price index, y/y % |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target federal funds rate, upper limit, average % |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unemployment rate, average % |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mexico |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real GDP growth, y/y % change |
- |
- |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unemployment rate, average % |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chile |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real GDP growth, y/y % change |
- |
- |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unemployment rate, average % |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Peru |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real GDP growth, y/y % change |
- |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unemployment rate, average % |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Colombia |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real GDP growth, y/y % change |
- |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unemployment rate, average % |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Caribbean |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real GDP growth, y/y % change |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Global |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
WTI oil price, average USD/bbl |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copper price, average USD/lb |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Global GDP, y/y % change |
- |
Base Case Scenario |
Alternative Scenario – Optimistic |
Alternative Scenario – Pessimistic |
Alternative Scenario – Very Pessimistic |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
October 31, 2022 |
Next 12 Months |
Remaining Forecast Period |
Next 12 Months |
Remaining Forecast Period |
Next 12 Months |
Remaining Forecast Period |
Next 12 Months |
Remaining Forecast Period |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Canada |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real GDP growth, y/y % change |
- |
- |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consumer price index, y/y % |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unemployment rate, average % |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bank of Canada overnight rate target, average % |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
HPI – Housing Price Index, y/y % change |
- |
- |
- |
- |
- |
- |
- |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
USD/CAD exchange rate, average |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
U.S. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real GDP growth, y/y % change |
- |
- |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consumer price index, y/y % |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target federal funds rate, upper limit, average % |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unemployment rate, average % |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mexico |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real GDP growth, y/y % change |
- |
- |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unemployment rate, average % |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chile |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real GDP growth, y/y % change |
- |
- |
- |
- |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unemployment rate, average % |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Peru |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real GDP growth, y/y % change |
- |
- |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unemployment rate, average % |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Colombia |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real GDP growth, y/y % change |
- |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unemployment rate, average % |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Caribbean |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real GDP growth, y/y % change |
- |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Global |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
WTI oil price, average USD/bbl |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copper price, average USD/lb |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Global GDP, y/y % change |
- |
- |
(iii) |
Sensitivity |
(iv) |
Allowance for credit losses |
($ millions) |
Balance as at November 1, 2022 |
Provision for credit losses (1) |
Net write-offs |
Other, including foreign currency adjustment |
Balance as at October 31, 2023 |
|||||||||||||||
Residential mortgages |
$ |
$ |
$ |
( |
) |
$ |
$ |
|||||||||||||
Personal loans |
( |
) |
||||||||||||||||||
Credit cards |
( |
) |
||||||||||||||||||
Business and government |
( |
) |
( |
) |
||||||||||||||||
$ |
$ |
$ |
( |
) |
$ |
$ |
||||||||||||||
Presented as: |
||||||||||||||||||||
Allowance for credit losses on loans |
$ |
$ |
||||||||||||||||||
Allowance for credit losses on acceptances |
||||||||||||||||||||
Allowance for credit losses on off-balance sheet exposures |
(1) | Excludes amounts associated with other assets of $( |
($ millions) | Balance as at November 1, 2021 |
Provision for credit losses |
Net write-offs |
Other, including foreign currency adjustment |
Balance as at October 31, 2022 |
|||||||||||||||
Residential mortgages |
$ | $ | $ | ( |
) | $ | $ | |||||||||||||
Personal loans |
( |
) | ||||||||||||||||||
Credit cards |
( |
) | ||||||||||||||||||
Business and government |
( |
) | ( |
) | ||||||||||||||||
$ | |
$ | |
$ | ( |
) | $ | |
$ | |
||||||||||
Presented as: |
||||||||||||||||||||
Allowance for credit losses on loans |
$ | $ | ||||||||||||||||||
Allowance for credit losses on acceptances |
||||||||||||||||||||
Allowance for credit losses on off-balance sheet exposures |
Allowance |
for credit losses on loans |
As at October 31, 2023 ($ millions) | Stage 1 |
Stage 2 |
Stage 3 |
Total |
||||||||||||
Residential mortgages |
$ |
$ |
$ |
$ |
||||||||||||
Personal loans |
||||||||||||||||
Credit cards |
– |
|||||||||||||||
Business and government |
||||||||||||||||
Total (1) |
$ |
$ |
$ |
$ |
(1) | Excludes allowance for credit losses for other financial assets including acceptances, investment securities, deposits with banks, off-balance sheet credit risks and reverse repos which amounted to $ |
As at October 31, 2022 ($ millions) | Stage 1 |
Stage 2 |
Stage 3 |
Total |
||||||||||||
Residential mortgages |
$ | $ | $ | $ | ||||||||||||
Personal loans |
||||||||||||||||
Credit cards |
– | |||||||||||||||
Business and government |
||||||||||||||||
Total (1) |
$ | |
$ | |
$ | |
$ | |
(1) | Excludes allowance for credit losses for other financial assets including acceptances, investment securities, deposits with banks, off-balance sheet credit risks and reverse repos which amounted to $ |
As at October 31, 2023 |
As at October 31, 2022 |
|||||||||||||||||||||||||||||||
($ millions) | Stage 1 |
Stage 2 |
Stage 3 |
Total |
Stage 1 |
Stage 2 |
Stage 3 |
Total |
||||||||||||||||||||||||
Residential mortgages |
||||||||||||||||||||||||||||||||
Balance at beginning of the year |
$ |
$ |
$ |
$ |
$ | $ | $ | $ | ||||||||||||||||||||||||
Provision for credit losses |
||||||||||||||||||||||||||||||||
Remeasurement (1) |
( |
) |
( |
) | ||||||||||||||||||||||||||||
Newly originated or purchased financial assets |
– |
– |
– | – | ||||||||||||||||||||||||||||
Derecognition of financial assets and maturities |
( |
) |
( |
) |
– |
( |
) |
( |
) | ( |
) | – | ( |
) | ||||||||||||||||||
Changes in models and methodologies |
– |
– |
– |
– |
– | – | – | – | ||||||||||||||||||||||||
Transfer to (from): |
||||||||||||||||||||||||||||||||
Stage 1 |
( |
) |
( |
) |
– |
( |
) | ( |
) | – | ||||||||||||||||||||||
Stage 2 |
( |
) |
( |
) |
– |
( |
) | ( |
) | – | ||||||||||||||||||||||
Stage 3 |
– |
( |
) |
– |
– | ( |
) | – | ||||||||||||||||||||||||
Gross write-offs | – |
– |
( |
) |
( |
) |
– | – | ( |
) | ( |
) | ||||||||||||||||||||
Recoveries | – |
– |
– | – | ||||||||||||||||||||||||||||
Foreign exchange and other movements (6) |
||||||||||||||||||||||||||||||||
Balance at end of year (2) |
$ |
$ |
$ |
$ |
$ | $ | $ | $ | ||||||||||||||||||||||||
Personal loans |
||||||||||||||||||||||||||||||||
Balance at beginning of the year |
$ |
$ |
$ |
$ |
$ | $ | $ | $ | ||||||||||||||||||||||||
Provision for credit losses |
||||||||||||||||||||||||||||||||
Remeasurement (1) |
( |
) |
( |
) | ||||||||||||||||||||||||||||
Newly originated or purchased financial assets |
– |
– |
– | – | ||||||||||||||||||||||||||||
Derecognition of financial assets and maturities |
( |
) |
( |
) |
– |
( |
) |
( |
) | ( |
) | – | ( |
) | ||||||||||||||||||
Changes in models and methodologies |
– |
– |
– |
– |
– | – | – | – | ||||||||||||||||||||||||
Transfer to (from): |
||||||||||||||||||||||||||||||||
Stage 1 |
( |
) |
( |
) |
– |
( |
) | ( |
) | – | ||||||||||||||||||||||
Stage 2 |
( |
) |
( |
) |
– |
( |
) | ( |
) | – | ||||||||||||||||||||||
Stage 3 |
( |
) |
( |
) |
– |
( |
) | ( |
) | – | ||||||||||||||||||||||
Gross write-offs | – |
– |
( |
) |
( |
) |
– | – | ( |
) | ( |
) | ||||||||||||||||||||
Recoveries | – |
– |
– | – | ||||||||||||||||||||||||||||
Foreign exchange and other movements (6) |
||||||||||||||||||||||||||||||||
Balance at end of year (2) |
$ |
$ |
$ |
$ |
$ | $ | $ | $ | ||||||||||||||||||||||||
Credit cards |
||||||||||||||||||||||||||||||||
Balance at beginning of the year |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||
Provision for credit losses |
||||||||||||||||||||||||||||||||
Remeasurement (1) |
( |
) |
( |
) | ||||||||||||||||||||||||||||
Newly originated or purchased financial assets |
– |
– |
– | – | ||||||||||||||||||||||||||||
Derecognition of financial assets and maturities |
( |
) |
( |
) |
– |
( |
) |
( |
) | ( |
) | – | ( |
) | ||||||||||||||||||
Changes in models and methodologies |
– |
– |
– |
– |
– | – | – | – | ||||||||||||||||||||||||
Transfer to (from): |
||||||||||||||||||||||||||||||||
Stage 1 |
( |
) |
– |
– |
( |
) | – | – | ||||||||||||||||||||||||
Stage 2 |
( |
) |
– |
– |
( |
) | – | – | ||||||||||||||||||||||||
Stage 3 |
– |
( |
) |
– |
– | ( |
) | – | ||||||||||||||||||||||||
Gross write-offs |
– |
– |
( |
) |
( |
) |
– | – | ( |
) | ( |
) | ||||||||||||||||||||
Recoveries |
– |
– |
– | – | ||||||||||||||||||||||||||||
Foreign exchange and other movements (6) |
||||||||||||||||||||||||||||||||
Balance at end of year (2) |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||
Total retail loans |
||||||||||||||||||||||||||||||||
Balance at beginning of the year |
$ |
$ |
$ |
$ |
$ | $ | $ | $ | ||||||||||||||||||||||||
Provision for credit losses |
– |
– |
– |
– |
– | – | – | – | ||||||||||||||||||||||||
Remeasurement (1) |
( |
) |
( |
) | ||||||||||||||||||||||||||||
Newly originated or purchased financial assets |
– |
– |
– | – | ||||||||||||||||||||||||||||
Derecognition of financial assets and maturities |
( |
) |
( |
) |
– |
( |
) |
( |
) | ( |
) | – | ( |
) | ||||||||||||||||||
Changes in models and methodologies |
– |
– |
– |
– |
– | – | – | – | ||||||||||||||||||||||||
Transfer to (from): |
– |
– |
– |
– |
– | – | – | – | ||||||||||||||||||||||||
Stage 1 |
( |
) |
( |
) |
– |
( |
) | ( |
) | – | ||||||||||||||||||||||
Stage 2 |
( |
) |
( |
) |
– |
( |
) | ( |
) | – | ||||||||||||||||||||||
Stage 3 |
( |
) |
( |
) |
– |
( |
) | ( |
) | – | ||||||||||||||||||||||
Gross write-offs |
– |
– |
( |
) |
( |
) |
– | – | ( |
) | ( |
) | ||||||||||||||||||||
Recoveries |
– |
– |
– | – | ||||||||||||||||||||||||||||
Foreign exchange and other movements (6) |
||||||||||||||||||||||||||||||||
Balance at end of year (2) |
$ |
$ |
$ |
$ |
$ | |
$ | |
$ | $ | ||||||||||||||||||||||
Business and government |
||||||||||||||||||||||||||||||||
Balance at beginning of the year |
$ |
$ |
$ |
$ |
$ | $ | $ | $ | ||||||||||||||||||||||||
Provision for credit losses |
||||||||||||||||||||||||||||||||
Remeasurement (1) |
( |
) | ( |
) | ||||||||||||||||||||||||||||
Newly originated or purchased financial assets |
– |
– |
– | – | ||||||||||||||||||||||||||||
Derecognition of financial assets and maturities |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Changes in models and methodologies |
– |
– |
– |
– |
– | |||||||||||||||||||||||||||
Transfer to (from): |
||||||||||||||||||||||||||||||||
Stage 1 |
( |
) |
– |
– |
( |
) | – | – | ||||||||||||||||||||||||
Stage 2 |
( |
) |
( |
) |
– |
( |
) | ( |
) | – | ||||||||||||||||||||||
Stage 3 |
– |
( |
) |
– |
– | ( |
) | – | ||||||||||||||||||||||||
Gross write-offs |
– |
– |
( |
) |
( |
) |
– | – | ( |
) | ( |
) | ||||||||||||||||||||
Recoveries |
– |
– |
– | – | ||||||||||||||||||||||||||||
Foreign exchange and other movements |
( |
) |
( |
) |
( |
) | ( |
) | ||||||||||||||||||||||||
Balance at end of period including off-balance sheet exposures(2) |
$ |
$ |
$ |
$ |
$ | $ | $ | $ | ||||||||||||||||||||||||
Less: Allowance for credits losses on off-balance sheet exposures(2)(3) |
||||||||||||||||||||||||||||||||
Balance at end of year (2) |
$ |
$ |
$ |
$ |
$ | $ | $ | $ |
(1) | Includes credit risk changes as a result of significant increases in credit risk, changes in credit risk that did not result in a transfer between stages, changes in model inputs and assumptions and changes due to drawdowns of undrawn commitments. |
(2) | Interest income on impaired loans for residential mortgages, personal loans, credit cards, and business and government loans totaled $ |
(3) | Allowance for credit losses on off-balance sheet exposures is recorded in other liabilities in the Consolidated Statement of Financial Position. |
(4) | Allowance for credit losses on acceptances are recorded against the financial asset in the Consolidated Statement of Financial Position. |
(5) | During the year ended October 31, 2023, the contractual terms of certain financial assets were modified where the modification did not result in derecognition. The carrying value of such loans that were modified in Stage 2 and Stage 3 was $ |
(6) | Divestitures are included in the foreign exchange and other movements. |
(f) |
Carrying value of exposures by risk rating |
Residential mortgages |
As at October 31, 2023 |
As at October 31, 2022 |
||||||||||||||||||||||||||||||
Category of PD grades ($ millions) |
Stage 1 |
Stage 2 |
Stage 3 (1) |
Total |
Stage 1 |
Stage 2 |
Stage 3 (1) |
Total |
||||||||||||||||||||||||
Very low |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||
Low |
– |
– | ||||||||||||||||||||||||||||||
Medium |
– |
– | ||||||||||||||||||||||||||||||
High |
– |
– | ||||||||||||||||||||||||||||||
Very high |
– |
– | ||||||||||||||||||||||||||||||
Loans not graded (2) |
– |
– | ||||||||||||||||||||||||||||||
Default |
– |
– |
– | – | |
|||||||||||||||||||||||||||
Total |
||||||||||||||||||||||||||||||||
Allowance for credit losses |
||||||||||||||||||||||||||||||||
Carrying value |
$ |
$ |
$ |
$ |
$ | |
$ | |
$ | |
$ | |
(1) | Stage 3 includes purchased or originated credit-impaired loans. |
(2) | Portfolios where the customer account level ‘Probability of Default’ has not been determined have been included in the ‘Loans not graded’ category. |
Personal loans |
As at October 31, 2023 |
As at October 31, 2022 |
||||||||||||||||||||||||||||||
Category of PD grades ($ millions) |
Stage 1 |
Stage 2 |
Stage 3 (1) |
Total |
Stage 1 |
Stage 2 |
Stage 3 (1) |
Total |
||||||||||||||||||||||||
Very low |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||
Low |
– |
– | ||||||||||||||||||||||||||||||
Medium |
– |
– | ||||||||||||||||||||||||||||||
High |
– |
– | ||||||||||||||||||||||||||||||
Very high |
– |
– | ||||||||||||||||||||||||||||||
Loans not graded (2) |
– |
– | ||||||||||||||||||||||||||||||
Default |
– |
– |
– | – | ||||||||||||||||||||||||||||
Total |
||||||||||||||||||||||||||||||||
Allowance for credit losses |
||||||||||||||||||||||||||||||||
Carrying value |
$ |
$ |
$ |
$ |
$ | |
$ | |
$ | |
$ | |
(1) | Stage 3 includes purchased or originated credit-impaired loans. |
(2) | Portfolios where the customer account level ‘Probability of Default’ has not been determined have been included in the ‘Loans not graded’ category. |
Credit cards |
As at October 31, 2023 |
As at October 31, 2022 |
||||||||||||||||||||||||||||||
Category of PD grades ($ millions) | Stage 1 |
Stage 2 |
Stage 3 |
Total |
Stage 1 |
Stage 2 |
Stage 3 |
Total |
||||||||||||||||||||||||
Very low |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||
Low |
– |
– | ||||||||||||||||||||||||||||||
Medium |
– |
– | ||||||||||||||||||||||||||||||
High |
– |
– | ||||||||||||||||||||||||||||||
Very high |
– |
– | ||||||||||||||||||||||||||||||
Loans not graded (1) |
– |
– | ||||||||||||||||||||||||||||||
Default |
– |
– |
– |
– |
– | – | – | – | ||||||||||||||||||||||||
Total |
– |
– | ||||||||||||||||||||||||||||||
Allowance for credit losses |
– |
– | ||||||||||||||||||||||||||||||
Carrying value |
$ |
$ |
$ |
– |
$ |
$ | |
$ | |
$ | – | $ | |
(1) | Portfolios where the customer account level ‘Probability of Default’ has not been determined have been included in the ‘Loans not graded’ category. |
Undrawn loan commitments – Retail |
As at October 31, 2023 |
As at October 31, 2022 |
||||||||||||||||||||||||||||||
Category of PD grades ($ millions) |
Stage 1 |
Stage 2 |
Stage 3 |
Total |
Stage 1 |
Stage 2 |
Stage 3 |
Total |
||||||||||||||||||||||||
Very low |
$ |
$ |
$ |
– |
$ |
$ |
$ |
$ |
– |
$ |
||||||||||||||||||||||
Low |
– |
– |
||||||||||||||||||||||||||||||
Medium |
– |
– |
||||||||||||||||||||||||||||||
High |
– |
– |
||||||||||||||||||||||||||||||
Very high |
– |
– |
||||||||||||||||||||||||||||||
Loans not graded (1) |
– |
– |
||||||||||||||||||||||||||||||
Default |
– |
– |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||
Carrying value |
$ |
$ |
$ |
– |
$ |
$ |
$ |
$ |
– |
$ |
(1) | Portfolios where the customer account level ‘Probability of Default’ has not been determined have been included in the ‘Loans not graded’ category. |
Total retail loans |
As at October 31, 2023 |
As at October 31, 2022 |
||||||||||||||||||||||||||||||
Category of PD grades ($ millions) | Stage 1 |
Stage 2 |
Stage 3 (1) |
Total |
Stage 1 |
Stage 2 |
Stage 3 (1) |
Total |
||||||||||||||||||||||||
Very low |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||
Low |
– |
– | ||||||||||||||||||||||||||||||
Medium |
– |
– | ||||||||||||||||||||||||||||||
High |
– |
– | ||||||||||||||||||||||||||||||
Very high |
– |
– | ||||||||||||||||||||||||||||||
Loans not graded (2) |
– |
– | ||||||||||||||||||||||||||||||
Default |
– |
– |
– | – | ||||||||||||||||||||||||||||
Total |
||||||||||||||||||||||||||||||||
Allowance for credit losses |
||||||||||||||||||||||||||||||||
Carrying value |
$ |
$ |
$ |
$ |
$ | |
$ | |
$ | |
$ | |
(1) | Stage 3 includes purchased or originated credit-impaired loans. |
(2) | Portfolios where the customer account level ‘Probability of Default’ has not been determined have been included in the ‘Loans not graded’ category. |
Business and government loans |
As at October 31, 2023 |
As at October 31, 2022 |
||||||||||||||||||||||||||||||
Category of PD grades ($ millions) | Stage 1 |
Stage 2 |
Stage 3 (1) |
Total |
Stage 1 |
Stage 2 |
Stage 3 (1) |
Total |
||||||||||||||||||||||||
Investment grade |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||
Non-Investment grade |
– |
– | ||||||||||||||||||||||||||||||
Watch list |
– |
– | ||||||||||||||||||||||||||||||
Loans not graded (2) |
– |
– | ||||||||||||||||||||||||||||||
Default |
– |
– |
– | – | ||||||||||||||||||||||||||||
Total |
||||||||||||||||||||||||||||||||
Allowance for credit losses |
||||||||||||||||||||||||||||||||
Carrying value |
$ |
$ |
$ |
$ |
$ | |
$ | |
$ | |
$ | |
(1) | Stage 3 includes purchased or originated credit-impaired loans. |
(2) | Portfolios where the customer account level ‘Probability of Default’ has not been determined have been included in the ‘Loans not graded’ category. |
Undrawn loan commitments – Business and government |
As at October 31, 2023 |
As at October 31, 2022 |
||||||||||||||||||||||||||||||
Category of PD grades ($ millions) | Stage 1 |
Stage 2 |
Stage 3 (1) |
Total |
Stage 1 |
Stage 2 |
Stage 3 (1) |
Total |
||||||||||||||||||||||||
Investment grade |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||
Non-investment grade |
– |
– | ||||||||||||||||||||||||||||||
Watch list |
– |
– | ||||||||||||||||||||||||||||||
Loans not graded (2) |
– |
– |
– | – | ||||||||||||||||||||||||||||
Default |
– |
– |
– | – | ||||||||||||||||||||||||||||
Total |
||||||||||||||||||||||||||||||||
Allowance for credit losses |
||||||||||||||||||||||||||||||||
Carrying value |
$ |
$ |
$ |
$ |
$ | |
$ | |
$ | |
$ | |
(1) | Stage 3 includes purchased or originated credit-impaired loans. |
(2) | Portfolios where the customer account level ‘Probability of Default’ has not been determined have been included in the ‘Loans not graded’ category. |
Total non-retail loans |
As at October 31, 2023 |
As at October 31, 2022 |
||||||||||||||||||||||||||||||
Category of PD grades ($ millions) | Stage 1 |
Stage 2 |
Stage 3 (1) |
Total |
Stage 1 |
Stage 2 |
Stage 3 (1) |
Total |
||||||||||||||||||||||||
Investment grade |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||
Non-investment grade |
– |
– | ||||||||||||||||||||||||||||||
Watch list |
– |
– | ||||||||||||||||||||||||||||||
Loans not graded (2) |
– |
– | ||||||||||||||||||||||||||||||
Default |
– |
– |
– | – | ||||||||||||||||||||||||||||
Total |
||||||||||||||||||||||||||||||||
Allowance for credit losses |
||||||||||||||||||||||||||||||||
Carrying value |
$ |
$ |
$ |
$ |
$ | |
$ | |
$ | |
$ | |
(1) | Stage 3 includes purchased or originated credit-impaired loans. |
(2) |
Portfolios where the customer account level ‘Probability of Default’ has not been determined have been included in the ‘Loans not graded’ category. |
(g) |
Loans past due but not impaired (1) |
2023 (2) |
2022 (2) |
|||||||||||||||||||||||||||||||
As at October 31 ($ millions) | 31 – 60 days |
61 – 90 days |
91 days and greater (3) |
Total |
31 – 60 days |
61 – 90 days |
91 days and greater (3) |
Total |
||||||||||||||||||||||||
Residential mortgages |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||
Personal loans |
– |
– | ||||||||||||||||||||||||||||||
Credit cards |
||||||||||||||||||||||||||||||||
Business and government |
– |
– | ||||||||||||||||||||||||||||||
Total |
$ |
$ |
$ |
$ |
$ | |
$ | |
$ | |
$ | |
(1) | Loans past due 30 days or less are not presented in this analysis as they are not administratively considered past due. |
(2) | |
(3) | All loans that are over 90 days past due are considered impaired with the exception of credit card receivables which are considered impaired when 180 days past due. |
(h) |
Purchased credit-impaired loans |
As at October 31 ($ millions) |
2023 |
2022 |
||||||
Unpaid principal balance (1) |
$ |
$ |
||||||
Credit related fair value adjustments |
( |
) |
( |
) | ||||
Carrying value |
||||||||
Stage 3 allowance |
( |
) |
( |
) | ||||
Carrying value net of related allowance |
$ |
$ |
(1) | Represents principal amount owed net of write-offs. |
14 |
Derecognition of Financial Assets |
As at October 31 ($ millions) | 2023 (1) |
2022 (1) |
||||||
Assets |
||||||||
Carrying value of residential mortgage loans |
$ |
$ | |
|||||
Other related assets (2) |
||||||||
Liabilities |
||||||||
Carrying value of associated liabilities |
(1) | The fair value of the transferred assets is $ |
(2) | These include cash held in trust and trust permitted investment assets, including repurchase style transactions of mortgage-backed securities, acquired as part of principal reinvestment account that the Bank is required to maintain in order to participate in the programs. |
As at October 31 ($ millions) |
2023 (1) |
2022 (1) |
||||||
Carrying value of assets associated with: |
||||||||
Repurchase agreements (2) |
$ |
$ |
||||||
Securities lending agreements |
||||||||
Total |
||||||||
Carrying value of associated liabilities (3) |
$ |
$ |
(1) |
The fair value of transferred assets is $ |
(2) |
Does not include over-collateralization of assets pledged. |
(3) |
Liabilities for securities lending arrangements only include amounts related to cash collateral received. For securities received as collateral, refer to Note 35(a)(iv) – Financial Instruments – Risk Management. |
15 |
Structured Entities |
(a) |
Consolidated structured entities |
(b) |
Unconsolidated structured entities |
As at October 31, 2023 |
||||||||||||||||
($ millions) |
Canadian multi-seller conduits that the Bank administers |
Structured finance entities |
Other funding vehicles |
Total |
||||||||||||
Total assets on structured entity’s financial statements |
$ |
$ |
$ |
$ |
||||||||||||
Assets recognized on the Bank’s financial statements |
||||||||||||||||
Trading assets |
– |
|||||||||||||||
Investment securities |
– |
|||||||||||||||
Loans (1) |
– |
|||||||||||||||
Other |
– |
|||||||||||||||
Liabilities recognized on the Bank’s financial statements |
||||||||||||||||
Deposits – Business and government |
– |
– |
||||||||||||||
Other |
– |
– |
||||||||||||||
– |
– |
|||||||||||||||
Bank’s maximum exposure to loss |
$ |
$ |
$ |
$ |
||||||||||||
As at October 31, 2022 |
||||||||||||||||
($ millions) |
Canadian multi-seller conduits that the Bank administers |
Structured finance entities |
Other funding vehicles |
Total |
||||||||||||
Total assets (on structured entity’s financial statements) |
$ |
$ |
$ |
$ |
||||||||||||
Assets recognized on the Bank’s financial statements |
||||||||||||||||
Trading assets |
– |
|||||||||||||||
Investment securities |
– |
|||||||||||||||
Loans (1) |
– |
|||||||||||||||
Liabilities recognized on the Bank’s financial statements |
||||||||||||||||
Deposits – Business and government |
– |
– |
||||||||||||||
– |
– |
|||||||||||||||
Bank’s maximum exposure to loss |
$ |
$ |
$ |
$ |
(1) | Loan balances are presented net of allowance for credit losses. |
(c) |
Other unconsolidated Bank-sponsored entities |
16 |
Property and Equipment |
($ millions) |
Land & Building |
Equipment |
Technology Assets |
Leasehold Improvements |
Right-of-use Assets |
Total |
||||||||||||||||||
Cost |
||||||||||||||||||||||||
Balance as at October 31, 2021 |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Additions |
||||||||||||||||||||||||
Disposals/Retirements |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Foreign currency adjustments and other |
( |
) | ||||||||||||||||||||||
Balance as at October 31, 2022 |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||
Additions |
||||||||||||||||||||||||
Disposals/Retirements |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||
Foreign currency adjustments and other |
||||||||||||||||||||||||
Balance as at October 31, 2023 |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||
Accumulated depreciation |
||||||||||||||||||||||||
Balance as at October 31, 2021 |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Depreciation |
||||||||||||||||||||||||
Disposals/Retirements |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Foreign currency adjustments and other |
( |
) | ||||||||||||||||||||||
Balance as at October 31, 2022 |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||
Depreciation |
||||||||||||||||||||||||
Disposals/Retirements |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||
Foreign currency adjustments and other |
( |
) |
||||||||||||||||||||||
Balance as at October 31, 2023 |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||
Net book value |
||||||||||||||||||||||||
Balance as at October 31, 2022 |
$ | $ | $ | $ | $ | $ | (1) | |||||||||||||||||
Balance as at October 31, 2023 |
$ |
$ |
$ |
$ |
$ |
$ |
(1) |
(1) | Includes $ |
17 |
Investments in Associates |
2023 |
2022 |
|||||||||||||||||||||||
As at October 31 ($ millions) | Country of incorporation |
Nature of business |
Ownership percentage |
Date of financial statements (1) |
Carrying value |
Carrying value |
||||||||||||||||||
Canadian Tire’s Financial Services business (CTFS) (2) |
– |
$ |
– |
$ | ||||||||||||||||||||
Bank of Xi’an Co. Ltd. (3) |
% |
|
||||||||||||||||||||||
Maduro & Curiel’s Bank N.V. (4) |
% |
(1) | Represents the date of the most recent financial statements. Where available, financial statements prepared by the associates’ management or other published information is used to estimate the change in the Bank’s interest since the most recent financial statements. |
(2) |
(3) |
(4) |
The local regulator requires financial institutions to set aside reserves for general banking risks. These reserves are not required under IFRS, and represent undistributed retained earnings related to a foreign associated corporation, which are subject to local regulatory restrictions. As of October 31, 2023 these reserves amounted to $ |
For the twelve months ended (1) |
As at October 31, 2023 |
|||||||||||||||
($ millions) | Revenue |
Net income |
Total assets |
Total liabilities |
||||||||||||
Canadian Tire’s Financial Services business (CTFS) |
$ |
$ |
$ |
n/a |
$ |
n/a |
||||||||||
Bank of Xi’an Co. Ltd. |
||||||||||||||||
Maduro & Curiel’s Bank N.V. |
For the twelve months ended (1) |
As at October 31, 2022 |
|||||||||||||||
($ millions) | Revenue |
Net income |
Total assets |
Total liabilities |
||||||||||||
Canadian Tire’s Financial Services business (CTFS) |
$ | $ | $ | |
$ | |||||||||||
Bank of Xi’an Co. Ltd. |
|
|
||||||||||||||
Maduro & Curiel’s Bank N.V. |
(1) |
18 |
Goodwill and Other Intangible Assets |
($ millions) | Canadian Banking |
Global Wealth Management |
Global Banking and Markets |
Latin America |
Caribbean and Central America |
Total |
||||||||||||||||||
Balance as at October 31, 2021 |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Acquisitions |
– | – | – | – | – | – | ||||||||||||||||||
Dispositions |
– | – | – | – | – | – | ||||||||||||||||||
Foreign currency adjustments and other |
– | ( |
) | |||||||||||||||||||||
Balance as at October 31, 2022 |
||||||||||||||||||||||||
Acquisitions |
– |
– |
– |
– |
– |
– |
||||||||||||||||||
Dispositions |
– |
– |
– |
– |
– |
– |
||||||||||||||||||
Foreign currency adjustments and other |
– |
|||||||||||||||||||||||
Balance as at October 31, 2023 |
$ |
$ |
$ |
$ |
$ |
$ |
Finite life |
Indefinite life |
|||||||||||||||||||||
($ millions) |
Computer software |
Other intangibles |
Fund management contracts (1) |
Other intangibles |
Total |
|||||||||||||||||
Cost |
||||||||||||||||||||||
Balance as at October 31, 2021 |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||
Acquisitions |
– |
– |
– |
– |
– |
|||||||||||||||||
Additions |
– |
– |
– |
|||||||||||||||||||
Disposals/Retirements |
( |
) |
– |
– |
– |
( |
) | |||||||||||||||
Foreign currency adjustments and other |
– |
– |
||||||||||||||||||||
Balance as at October 31, 2022 |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||
Acquisitions |
– |
– |
– |
– |
– |
|||||||||||||||||
Additions |
– |
– |
– |
|||||||||||||||||||
Impairment (3) |
( |
) |
( |
) |
– |
( |
) |
( |
) | |||||||||||||
Disposals/Retirements |
( |
) |
( |
) |
– |
– |
( |
) | ||||||||||||||
Foreign currency adjustments and other |
– |
– |
||||||||||||||||||||
Balance as at October 31, 2023 |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||
Accumulated amortization |
||||||||||||||||||||||
Balance as at October 31, 2021 |
$ |
$ |
$ |
– |
$ |
– |
$ |
|||||||||||||||
Amortization |
– |
– |
||||||||||||||||||||
Disposals/Retirements |
( |
) |
– |
– |
– |
( |
) | |||||||||||||||
Foreign currency adjustments and other |
– |
– |
||||||||||||||||||||
Balance as at October 31, 2022 |
$ |
$ |
$ |
– |
$ |
– |
$ |
|||||||||||||||
Amortization |
– |
– |
||||||||||||||||||||
Impairment (3) |
( |
) |
( |
) |
– |
– |
( |
) | ||||||||||||||
Disposals/Retirements |
( |
) |
( |
) |
– |
– |
( |
) | ||||||||||||||
Foreign currency adjustments and other |
( |
) |
– |
– |
( |
) | ||||||||||||||||
Balance as at October 31, 2023 |
$ |
$ |
$ |
– |
$ |
– |
$ |
|||||||||||||||
Net book value |
||||||||||||||||||||||
As at October 31, 2022 |
$ |
(2) |
$ |
$ |
$ |
$ |
||||||||||||||||
As at October 31, 2023 |
$ |
(2) |
$ |
$ |
$ |
$ |
(1) | Fund management contracts are attributable to the previously acquired Dynamic Funds business (formerly DundeeWealth Inc.), MD Financial Management Inc., and Jarislowsky Fraser Limited. |
(2) | Computer software comprises of purchased software of $ |
(3) | Impairment charges taken against finite life intangible assets primarily relate to the full write-off of a contract-based intangible asset in Peru, and software assets which were decommissioned in Q4 2023. |
19 |
Other Asse ts |
As at October 31 ($ millions) | 2023 |
2022 |
||||||
Accrued interest |
$ |
$ | ||||||
Accounts receivable and prepaids |
||||||||
Current tax assets |
||||||||
Margin deposits on derivatives |
||||||||
Segregated fund assets |
||||||||
Pension assets (Note 28) |
||||||||
Receivable from brokers, dealers and clients |
||||||||
Other |
||||||||
Total |
$ |
$ | |
20 |
Deposits |
2023 |
2022 |
|||||||||||||||||||||||
Payable on demand (1) |
||||||||||||||||||||||||
As at October 31 ($ millions) | Interest- bearing |
Non-interest- bearing |
Payable after notice (2) |
Payable on a fixed date (3) |
Total |
|||||||||||||||||||
Personal |
$ |
$ |
$ |
$ |
$ |
$ | ||||||||||||||||||
Business and government |
||||||||||||||||||||||||
Financial institutions |
||||||||||||||||||||||||
Total |
$ |
$ |
$ |
(4) |
$ |
$ |
$ | |||||||||||||||||
Recorded in: |
||||||||||||||||||||||||
Canada |
$ |
$ |
$ |
$ |
$ |
$ | ||||||||||||||||||
United States |
||||||||||||||||||||||||
United Kingdom |
– |
– |
||||||||||||||||||||||
Mexico |
– |
|||||||||||||||||||||||
Peru |
||||||||||||||||||||||||
Chile |
||||||||||||||||||||||||
Colombia |
||||||||||||||||||||||||
Other International |
||||||||||||||||||||||||
Total (5) |
$ |
$ |
$ |
$ |
$ |
$ | |
(1) | Deposits payable on demand include all deposits for which we do not have the right to notice of withdrawal, generally chequing accounts. |
(2) | Deposits payable after notice include all deposits for which we require notice of withdrawal, generally savings accounts. |
(3) | All deposits that mature on a specified date, generally term deposits, guaranteed investments certificates and similar instruments. |
(4) | Includes $ non-interest bearing deposits. |
(5) | Deposits denominated in U.S. dollars amount to $ |
($ millions) | Within three months |
Three to six months |
Six to twelve months |
One to five years |
Over five years |
Total |
||||||||||||||||||
As at October 31, 2023 |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||
As at October 31, 2022 |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
(1) | The majority of foreign term deposits are in excess of $ |
21 |
Subordinated Debentures |
As at October 31 ($ millions) |
2023 |
2022 |
||||||||||||
Maturity date |
Interest rate (%) |
Terms (1) |
Carrying value (2) |
Carrying value (2) |
||||||||||
$ |
$ |
|||||||||||||
(3) |
||||||||||||||
(3) |
||||||||||||||
(3) |
% or the applicable alternative rate, including adjustments, as specified in the terms of the instrument. |
|||||||||||||
Floating |
– |
|||||||||||||
(3) |
. S. $ |
|||||||||||||
(3) |
||||||||||||||
(3) |
– |
|||||||||||||
(3) |
– |
|||||||||||||
(3) |
– |
|||||||||||||
$ |
$ |
(1) | In accordance with the provisions of the Capital Adequacy Guideline of the Superintendent, all redemptions are subject to regulatory approval and subject to the terms in the relevant prospectus. |
(2) | The carrying value of subordinated debentures may differ from par value due to the impact of fair value hedges used for managing interest rate risk and subordinated debentures held for market-making purposes. |
(3) | These debentures contain non-viability contingent capital (NVCC) provisions. Under such NVCC provisions, outstanding debentures are convertible into a variable number of common shares if OSFI announces that the Bank has ceased, or is about to cease, to be viable, or if a federal or provincial government in Canada publicly announces that the Bank has accepted or agreed to accept a capital injection, or equivalent support, from the federal government or any provincial government or political subdivision or agent thereof without which the Bank would have been determined by OSFI to be non-viable. If such a conversion were to occur, the debentures would be converted into common shares pursuant to an automatic conversion formula defined as % of the par value plus accrued and unpaid interest divided by the conversion price and, where applicable, subject to translation at foreign exchange rates in effect at the time of conversion. The conversion price is based on the greater of: (i) a floor price of $ (subject to adjustments in certain events as set out in the respective prospectus supplements), and (ii) the current market price of the Bank’s common shares at the time of the trigger event (10-day we i ghted average). |
22 |
Other Liabilities |
As at October 31 ($ millions) | 2023 |
2022 |
||||||
Accrued interest |
$ |
$ | ||||||
Lease liabilities (1) |
||||||||
Accounts payable and accrued expenses |
||||||||
Current tax liabilities |
||||||||
Deferred tax liabilities (Note 27) |
||||||||
Gold and silver certificates and bullion |
||||||||
Margin and collateral accounts |
||||||||
Segregated fund liabilities |
||||||||
Payables to brokers, dealers and clients |
||||||||
Provisions (Note 23) |
||||||||
Allowance for credit losses on off-balance sheet exposures13 ) |
||||||||
Pension liabilities (Note 28) |
||||||||
Other liabilities of subsidiaries and structured entities |
||||||||
Other |
||||||||
Total |
$ |
$ | |
(1) | Represents discounted value of lease liabilities. |
As at October 31 ($ millions) |
2023 |
2022 |
||||||
Within 1 year |
$ |
$ |
||||||
1 to 2 years |
||||||||
2 to 3 years |
||||||||
3 to 4 years |
||||||||
4 to 5 years |
||||||||
After 5 years |
||||||||
Total |
$ |
$ |
23 |
Provisions |
($ millions) | ||||
As at November 1, 2021 |
$ | |||
Provisions made during the year |
||||
Provisions utilized / released during the year |
( |
) | ||
Balance as at October 31, 2022 |
$ | |||
Provisions made during the year |
||||
Provisions utilized / released during the year |
( |
) | ||
Balance as at October 31, 2023 |
$ |
24 |
Common shares, preferred shares and other equity instruments |
(a) |
Common shares |
2023 |
2022 |
|||||||||||||||
As at October 31 ($ millions) | Number of shares |
Amount |
Number of shares |
Amount |
||||||||||||
Outstanding at beginning of year |
$ |
$ | ||||||||||||||
Issued in relation to share-based payments, net (Note 26) |
||||||||||||||||
Issued in relation to the acquisition of a subsidiary or associated corporation |
– |
– |
||||||||||||||
Issued in relation to the Shareholder Dividend and Share Purchase Plan (1) |
– | – | ||||||||||||||
Repurchased for cancellation under the Normal Course Issuer Bid |
– |
– |
( |
) | ( |
) | ||||||||||
Outstanding at end of year |
( 2) |
$ |
(2) |
$ | |
(1) | Commencing with the dividend declared on February 28, 2023 and paid on April 26, 2023, the Bank issued to participants of the Shareholder Dividend and Share Purchase Plan (the “Plan”), common shares from treasury with a discount of |
(2) | In the normal course of business, the Bank’s regulated Dealer subsidiary purchases and sells the Bank’s common shares to facilitate trading/institutional client activity. During fiscal 2023, the number of such shares bought was |
(b) |
Preferred shares and other equity instruments |
2023 |
2022 |
|||||||||||||||||||||||||||||||
As at October 31 ($ millions) | Number of shares |
Amount |
Dividends declared per share (1) |
Conversion feature |
Number of shares |
Amount |
Dividends declared per share |
Conversion feature |
||||||||||||||||||||||||
NVCC Preferred shares: (a) |
||||||||||||||||||||||||||||||||
Series 38 (b) |
– |
– |
– |
– |
– | – | Series 39 |
|||||||||||||||||||||||||
Series 40 (c) |
||||||||||||||||||||||||||||||||
Total preferred shares |
$ |
$ | |
(1) | Dividends declared from November 1, 2022 to October 31, 2023. |
First issue date |
Issue price |
Initial dividend |
Initial dividend payment date |
Rate reset spread |
Redemption date |
Redemption price |
||||||||||||||||||||||
NVCC Preferred shares (a) : |
||||||||||||||||||||||||||||
Series 40 (c) |
% |
(a) | Non-cumulative preferential cash dividends on all series are payable Non-cumulative 5-year Government of Canada Yield plus the indicated rate reset spread, multiplied by $non-cumulative preferential cash dividends on the Series 41 are payable Non-cumulative non-cumulative preferred share dividends. |
(b) | On January 27, 2022 the Bank redeemed all outstanding Non-cumulative Preferred Shares Series 38 at a price equal to $ |
(c) | Holders of Non-cumulative 5-Year Rate Reset Preferred Shares Series 40 (NVCC) will have the option to convert shares into an equal number of Non-cumulative Floating Rate Preferred Shares Series 41 (NVCC) on January 27, 2024, and on January 27 every five years thereafter. If outstanding, holders of Non-cumulative Floating Rate Reset Preferred Shares Series 41 (NVCC) will have the option to convert shares into an equal number of Non-cumulative 5-Year Rate Reset Preferred Shares Series 40 (NVCC) on January 27, 2029, and on January 27 every five years thereafter. With respect to Series 40 and 41, if the Bank determines that, after giving effect to any Election Notices received, there would be less than |
2023 |
2022 |
|||||||||||||||||||||||||||||||||||||||
First issue date/ Series number |
Notional Amount (millions) |
Next reset date |
Interest rate |
Interest rate after reset |
Next redemption date |
Redemption frequency after reset (1) |
Amount |
Distributions paid per Note (2) |
Amount |
Distributions paid per Note (2) |
||||||||||||||||||||||||||||||
Subordinated Additional Tier 1 Capital Notes (3)(4) |
||||||||||||||||||||||||||||||||||||||||
(5) |
U.S.$ | |
January 12, 2024 |
|
% | + |
(5) % |
January 12, 2024 |
|
$ |
U.S.$ |
$ | U.S.$ | |
||||||||||||||||||||||||||
U.S.$ | June 4, 2025 |
|
% | + |
(6) % |
June 4, 2025 |
|
|
$ |
U.S.$ |
$ | U.S.$ | ||||||||||||||||||||||||||||
Limited Recourse Capital Notes (3)(7) |
||||||||||||||||||||||||||||||||||||||||
Series 1 (8) |
$ | July 27, 2026 |
|
% | + |
(9) % |
June 27, 2026 |
|
|
$ |
$ |
$ | $ | |||||||||||||||||||||||||||
Series 2 (10) |
U.S.$ | October 27, 2026 |
|
% | + |
(6) % |
October 27, 2026 |
|
$ |
U.S.$ |
$ | U.S.$ | ||||||||||||||||||||||||||||
Series 3 (11) |
$ | July 27, 2027 |
|
% | + |
(9) % |
June 27, 2027 |
|
|
$ |
$ |
$ | $ | |||||||||||||||||||||||||||
Series 4 (12) |
U.S.$ | October 27, 2027 |
|
% | + |
(6) % |
October 27, 2027 |
|
$ |
U.S.$ |
$ | U.S.$ | – | |||||||||||||||||||||||||||
Total other equity instruments |
$ |
$ | |
(1) | Each security is redeemable at the sole discretion of the Bank on the first reset date and every quarter or five years, as applicable, thereafter. Limited Recourse Capital Notes (LRCN) Series 1 and Series 3 are also redeemable in the one month period preceding each reset date. The securities are also redeemable following a regulatory or tax event, as described in the offering documents. All redemptions are subject to regulatory consent and occur at a redemption price of par plus accrued and unpaid interest (unless canceled, where applicable). |
(2) | Distributions paid from November 1 to October 31 in the relevant fiscal year per face amount of $ . S. $ |
(3) | The securities rank pari passu to each other and are the Bank’s direct unsecured obligations, ranking subordinate to Bank’s other subordinated indebtedness. |
(4) | While interest is payable on the securities when it becomes due, the Bank may, at its sole discretion and with notice, cancel interest payments. Refer to Note 24(c) – Restriction on payment of dividends and retirement of shares. |
(5) | CME 3-month Term SOFR. In respect of these securities, on June 28, 2023, the Bank announced the interest rate transition from three-month USD LIBOR to three-month Term SOFR, plus a spread adjustment of 26.161 bps, for interest periods commencing on or after July 12, 2023. |
(6) | The then-prevailing five-year U.S. Treasury Rate. |
(7) | Interest on LRCN is non-deferrable, however, non-payment of interest that is not cured within results in a Recourse Event. A Recourse Event of the respective Series occurs if (a) there is non-payment in cash by the Bank of the principal amount, together with any accrued and unpaid interest, on the maturity date, (b) there is non-payment in cash of interest which is not cured within 5 business days, (c) there is non-payment in cash of the redemption price in connection with the redemption of the LRCNs, (d) an event of default occurs (i.e. bankruptcy, insolvency, or liquidation of the Bank), or (e) there is an NVCC Trigger Event. Upon the occurrence of a Recourse Event, the noteholder’s sole recourse will be limited to their proportionate share of the Series’ respective assets held in Scotiabank LRCN Trust, a consolidated entity, which consist initially of the respective AT1 Notes or, following an NVCC Trigger Event, common shares. Refer to Note 24(c) – Restriction on payment of dividends and retirement of shares. |
(8) | On June 15, 2021, the Bank issued $ |
(9) | The then-prevailing five-year Government of Canada yield. |
(10) | On October 7, 2021, the Bank issued U . S. $. S. $ |
(11) | On June 16, 2022, the Bank issued $ |
(12) | On October 25, 2022, the Bank issued U . S. $. S. $ |
(c) |
Restrictions on payment of dividends and retirement of shares |
25 |
Capital Management |
As at October 31 ($ millions) | 2023 |
2022 |
||||||
Revised Basel III |
Basel III |
|||||||
Capital (1)(2) |
||||||||
Common Equity Tier 1 capital |
$ |
$ | ||||||
Net Tier 1 capital |
||||||||
Total regulatory capital |
||||||||
Total loss absorbing capacity (TLAC) (3) |
||||||||
Risk-weighted assets/exposures used in calculation of capital ratios |
||||||||
Risk-weighted assets (1)(2) |
$ |
$ | ||||||
Leverage exposures (4) |
|
|||||||
Regulatory ratios (1)(2) |
||||||||
Common Equity Tier 1 capital ratio |
% |
% | ||||||
Tier 1 capital ratio |
% |
% | ||||||
Total capital ratio |
% |
% | ||||||
Total loss absorbing capacity ratio (3) |
% |
% | ||||||
Leverage ratio (4) |
% |
% | ||||||
Total loss absorbing capacity leverage ratio (3) |
% |
% |
(1) |
Regulatory ratios and amounts reported in 2023 are under Revised Basel III requirements and are not directly comparable to ratios and amounts reported in 2022. |
(2) |
2023 regulatory capital ratios are based on Revised Basel III requirements as determined in accordance with OSFI Guideline – Capital Adequacy Requirements (February 2023). Prior year regulatory capital ratios were prepared in accordance with OSFI Guideline – Capital Adequacy Requirements (November 2018). |
(3) |
This measure has been disclosed in this document in accordance with OSFI Guideline – Total Loss Absorbing Capacity (September 2018). |
(4) |
2023 leverage ratios are based on Revised Basel III requirements as determined in accordance with OSFI Guideline – Leverage Requirements (February 2023). Prior year leverage ratios were prepared in accordance with OSFI Guideline – Leverage Requirements (November 2018). |
26 |
Share-Based Payments |
(a) |
Stock option plans |
• |
Stock options |
• |
Stock appreciation rights |
2023 Grant |
2022 Grant |
|||||||
Assumptions |
||||||||
Risk-free interest rate % |
||||||||
Expected dividend yield |
||||||||
Expected price volatility |
||||||||
Expected life of option |
||||||||
Fair value |
||||||||
Weighted-average fair value |
$ |
$ |
2023 |
2022 |
|||||||||||||||
As at October 31 | Number of stock options (000’s) |
Weighted average exercise price |
Number of stock options (000’s) |
Weighted average exercise price |
||||||||||||
Outstanding at beginning of year |
$ |
$ | |
|||||||||||||
Granted |
||||||||||||||||
Exercised as options |
( |
) |
( |
) | ||||||||||||
Exercised as SARs |
( |
) |
( |
) | ||||||||||||
Forfeited |
( |
) |
( |
) | ||||||||||||
Expired |
( |
) |
– | – | ||||||||||||
Outstanding at end of year |
$ |
$ | ||||||||||||||
Exercisable at end of year |
$ |
$ | ||||||||||||||
Available for grant |
Options Outstanding |
Options Exercisable |
|||||||||||||||||||
As at October 31, 2023 | Number of stock options (000’s) |
Weighted average remaining contractual life (years) |
Weighted average exercise price |
Number of stock options (000’s) |
Weighted average exercise price |
|||||||||||||||
Range of exercise prices |
||||||||||||||||||||
$ |
$ |
$ |
||||||||||||||||||
$ |
$ |
$ |
||||||||||||||||||
$ |
$ |
$ |
||||||||||||||||||
$ |
$ |
(1) | Excludes SARs. |
(b) |
Employee share ownership plans |
(c) |
Other share-based payment plans |
27 |
Corporate Income Taxes |
(a) |
Components of income tax provision |
For the year ended October 31 ($ millions) |
2023 |
2022 |
||||||
Provision for income taxes in the Consolidated Statement of Income: |
||||||||
Current income taxes: |
||||||||
Domestic: |
||||||||
Federal |
$ |
$ |
||||||
Provincial |
||||||||
Adjustments related to prior periods |
( |
) | ||||||
Foreign |
||||||||
Adjustments related to prior periods |
( |
) |
( |
) | ||||
Deferred income taxes: |
||||||||
Domestic: |
||||||||
Federal |
( |
) |
( |
) | ||||
Provincial |
( |
) |
( |
) | ||||
Foreign |
( |
) |
||||||
( |
) |
( |
) | |||||
Total provision for income taxes in the Consolidated Statement of Income |
$ |
$ |
||||||
Provision for income taxes in the Consolidated Statement of Changes in Equity: |
||||||||
Current income taxes |
$ |
( |
) |
$ |
( |
) | ||
Deferred income taxes |
( |
) |
||||||
( |
) |
( |
) | |||||
Reported in: |
||||||||
Other Comprehensive Income |
( |
) |
( |
) | ||||
Retained earnings |
( |
) |
( |
) | ||||
Other reserves |
– |
– |
||||||
Total provision for income taxes in the Consolidated Statement of Changes in Equity |
( |
) |
( |
) | ||||
Total provision for income taxes |
$ |
$ |
||||||
Provision for income taxes in the Consolidated Statement of Income includes: |
||||||||
Deferred tax expense (benefit) relating to origination/reversal of temporary differences |
$ |
( |
) |
$ |
( |
) | ||
Deferred tax expense (benefit) of tax rate changes |
( |
) |
– |
|||||
$ |
( |
) |
$ |
( |
) |
(b) |
Reconciliation to statutory rate |
2023 |
2022 |
|||||||||||||||
For the year ended October 31 ($ millions) | Amount |
Percent of pre-tax income |
Amount |
Percent of pre-tax income |
||||||||||||
Income taxes at Canadian statutory rate |
$ |
% |
$ | |
% | |||||||||||
Increase (decrease) in income taxes resulting from: |
||||||||||||||||
Lower average tax rate applicable to subsidiaries and foreign branches |
( |
) |
( |
) |
( |
) | ( |
) | ||||||||
Tax-exempt income from securities |
( |
) |
( |
) |
( |
) | ( |
) | ||||||||
Other, net (1) |
||||||||||||||||
Total income taxes and effective tax rate (2) |
$ |
% |
$ | % |
(1) |
Includes $ tax benefit from the non-taxable gain related to the divestiture of the equity interest in CTFS. |
(2) |
The federal statutory income tax rate increased by |
(c) |
Deferred taxes |
Statement of Income |
Statement of Financial Position |
|||||||||||||||
For the year ended |
As at |
|||||||||||||||
October 31 ($ millions) |
2023 |
2022 |
2023 |
2022 |
||||||||||||
Deferred tax assets: |
||||||||||||||||
Loss carryforwards |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
||||||||
Allowance for credit losses |
( |
) |
( |
) |
||||||||||||
Deferred compensation |
( |
) |
||||||||||||||
Deferred income |
( |
) |
||||||||||||||
Property and equipment |
( |
) |
( |
) |
||||||||||||
Pension and other post-retirement benefits |
( |
) |
||||||||||||||
Securities |
( |
) |
( |
) |
||||||||||||
Lease liabilities |
( |
) |
( |
) |
||||||||||||
Cash flow hedges |
– |
– |
– |
– |
||||||||||||
Other |
( |
) |
( |
) |
||||||||||||
Total deferred tax assets |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
||||||||
Deferred tax liabilities: |
||||||||||||||||
Cash flow hedges |
$ |
– |
$ |
– |
$ |
$ |
||||||||||
Deferred compensation |
( |
) |
( |
) |
||||||||||||
Deferred income |
( |
) |
( |
) |
||||||||||||
Property and equipment |
||||||||||||||||
Pension and other post-retirement benefits |
( |
) |
||||||||||||||
Securities |
( |
) |
( |
) |
||||||||||||
Investment in subsidiaries and associates |
( |
) |
||||||||||||||
Intangible assets |
||||||||||||||||
Other |
( |
) |
( |
) |
||||||||||||
Total deferred tax liabilities |
$ |
$ |
( |
) |
$ |
$ |
||||||||||
Net deferred tax assets (liabilities) (1) |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
(1) | For Consolidated Statement of Financial Position presentation, deferred tax assets and liabilities are assessed by legal entity. As a result, the net deferred tax assets of $ |
For the year ended October 31 ($ millions) | 2023 |
2022 |
||||||
Balance at beginning of year |
$ |
$ | |
|||||
Deferred tax benefit (expense) for the year recorded in income |
||||||||
Deferred tax benefit (expense) for the year recorded in equity |
( |
) | ||||||
Disposed in divestitures |
– |
– | ||||||
Other |
||||||||
Balance at end of year |
$ |
$ |
28 |
Employee Benefits |
• | The Human Capital and Compensation Committee (HCOB) of the Board approves the charter of the Pension Administration and Investment Committee (PAIC), reviews reports, and approves the investment policy. The HCOB also reviews and recommends any amendments to the SPP to the Board of Directors. |
• | PAIC is responsible for recommending the investment policy to the HCOB, for appointing and monitoring investment managers, and for reviewing auditor and actuary reports. PAIC also monitors the administration of member pension benefits. |
• | The Scotiabank Master Trust Committee (MTC) invests assets in accordance with the investment policy and all applicable legislation. The MTC assigns specific mandates to investment managers. |
• | The Capital Accumulation Plans (CAP) Committee is responsible for the administration and investment of the DC component of the SPP including the selection and monitoring of investment options available to DC participants. |
• | there is a decline in discount rates; and/or |
• | plan assets returns are less than expected; and/or |
• | plan members live longer than expected; and/or |
• | health care costs are higher than assumed. |
a) |
Relative size of plan obligations and assets |
Pension plans |
Other benefit plans |
|||||||||||||||||||
Canada |
||||||||||||||||||||
For the year ended October 31, 2023 | SPP |
Other |
International |
Canada |
International |
|||||||||||||||
Percentage of total benefit obligations |
% |
% |
% |
% |
% | |||||||||||||||
Percentage of total plan assets |
% |
% |
% |
% |
% | |||||||||||||||
Percentage of total benefit expense (1) |
% |
% |
% |
% |
% |
Pension plans |
Other benefit plans |
|||||||||||||||||||
Canada |
||||||||||||||||||||
For the year ended October 31, 2022 | SPP |
Other |
International |
Canada |
International |
|||||||||||||||
Percentage of total benefit obligations |
% | % | % | % | % | |||||||||||||||
Percentage of total plan assets |
% | % | % | % | % | |||||||||||||||
Percentage of total benefit expense (1) |
% | % | % | % | % |
(1) | Excludes non-routine benefit expense items such as past service costs, curtailment charges and settlement charges. |
b) |
Cash contributions and payments |
Contributions to the principal plans for the year ended October 31 ($ millions) | 2023 |
2022 |
||||||
Defined benefit pension plans (cash contributions to fund the plans, including paying beneficiaries under the unfunded pension arrangements) |
||||||||
SPP (excluding DC provision) |
$ |
$ | |
|||||
All other plans |
||||||||
Other benefit plans (cash contributions mainly in the form of benefit payments to beneficiaries) |
||||||||
Defined contribution pension and other benefit plans (cash contributions) |
||||||||
DC pension contributions funded from pension plan surplus |
( |
) |
– | |||||
Total contributions (1) |
$ |
$ |
(1) | Based on preliminary estimates, the Bank expects to make contributions of $ |
c) |
Funded and unfunded plans |
Pension plans |
Other benefit plans |
|||||||||||||||
As at October 31 ($ millions) | 2023 |
2022 |
2023 |
2022 |
||||||||||||
Benefit obligation |
||||||||||||||||
Benefit obligation of plans that are wholly unfunded |
$ |
$ | $ |
$ | ||||||||||||
Benefit obligation of plans that are wholly or partly funded |
||||||||||||||||
Funded status |
||||||||||||||||
Benefit obligation of plans that are wholly or partly funded |
$ |
$ | |
$ |
$ | |||||||||||
Fair value of assets |
||||||||||||||||
Excess (deficit) of fair value of assets over benefit obligation of wholly or partly funded plans |
$ |
$ | $ |
( |
) |
$ | ( |
) | ||||||||
Benefit obligation of plans that are wholly unfunded |
||||||||||||||||
Excess (deficit) of fair value of assets over total benefit obligation |
$ |
$ | $ |
( |
) |
$ | ( |
) | ||||||||
Effect of asset limitation and minimum funding requirement |
( |
) |
( |
) | – |
– | ||||||||||
Net asset (liability) at end of year |
$ |
$ | $ |
( |
) |
$ | ( |
) |
d) |
Financial information |
Pension plans |
Other benefit plans |
|||||||||||||||
For the year ended October 31 ($ millions) | 2023 |
2022 |
2023 |
2022 |
||||||||||||
Change in benefit obligation |
||||||||||||||||
Benefit obligation at beginning of year |
$ |
$ | |
$ |
$ | |||||||||||
Current service cost |
||||||||||||||||
Interest cost on benefit obligation |
||||||||||||||||
Employee contributions |
– |
– | ||||||||||||||
Benefits paid |
( |
) |
( |
) | ( |
) |
( |
) | ||||||||
Actuarial loss (gain) |
( |
) |
( |
) | ( |
) |
( |
) | ||||||||
Past service cost |
( |
) |
( |
) |
( |
) | ||||||||||
Business acquisition |
– |
– | ( |
) |
– | |||||||||||
Settlements |
– |
– | – |
( |
) | |||||||||||
Foreign exchange |
||||||||||||||||
Benefit obligation at end of year |
$ |
$ | $ |
$ | ||||||||||||
Change in fair value of assets |
||||||||||||||||
Fair value of assets at beginning of year |
||||||||||||||||
Interest income on fair value of assets |
||||||||||||||||
Return on plan assets in excess of (less than) interest income on fair value of assets |
( |
) |
( |
) | ( |
) | ||||||||||
Employer contributions |
||||||||||||||||
Employee contributions |
– |
– | ||||||||||||||
Benefits paid |
( |
) |
( |
) | ( |
) |
( |
) | ||||||||
Administrative expenses |
( |
) |
( |
) | – |
– | ||||||||||
Business acquisition |
– |
– | – |
– | ||||||||||||
Settlements |
– |
– | – |
( |
) | |||||||||||
Foreign exchange |
||||||||||||||||
Fair value of assets at end of year |
$ |
$ | $ |
$ | ||||||||||||
Funded status |
||||||||||||||||
Excess (deficit) of fair value of assets over benefit obligation at end of year |
( |
) |
( |
) | ||||||||||||
Effect of asset limitation and minimum funding requirement (1) |
( |
) |
( |
) | – |
– | ||||||||||
Net asset (liability) at end of year |
$ |
$ | $ |
( |
) |
$ | ( |
) | ||||||||
Recorded in: |
||||||||||||||||
Other assets in the Bank’s Consolidated Statement of Financial Position |
||||||||||||||||
Other liabilities in the Bank’s Consolidated Statement of Financial Position |
( |
) |
( |
) | ( |
) |
( |
) | ||||||||
Net asset (liability) at end of year |
$ |
$ | $ |
( |
) |
$ | ( |
) | ||||||||
Annual benefit expense |
||||||||||||||||
Current service cost |
||||||||||||||||
Net interest expense (income) |
( |
) |
( |
) | ||||||||||||
Administrative expenses |
– |
– | ||||||||||||||
Past service costs |
( |
) |
( |
) |
( |
) | ||||||||||
Amount of settlement (gain) loss recognized |
– |
– | – |
– | ||||||||||||
Remeasurement of other long-term benefits |
– |
– | ( |
) |
( |
) | ||||||||||
Benefit expense (income) recorded in the Consolidated Statement of Income |
$ |
$ | $ |
$ | ||||||||||||
Defined contribution benefit expense |
$ |
$ | $ |
$ | ||||||||||||
Remeasurements |
||||||||||||||||
(Return) on plan assets in excess of interest income on fair value of assets |
( |
) |
||||||||||||||
Actuarial loss (gain) on benefit obligation |
( |
) |
( |
) | ( |
) |
( |
) | ||||||||
Change in the asset limitation |
( |
) |
– |
– | ||||||||||||
Remeasurements recorded in OCI |
$ |
( |
) |
$ | ( |
) | $ |
( |
) |
$ | ( |
) | ||||
Total benefit cost |
$ |
$ | ( |
) | $ |
$ | ( |
) | ||||||||
Additional details on actual return on assets and actuarial (gains) and losses |
||||||||||||||||
Actual return on assets (net of administrative expenses) |
$ |
$ | ( |
) | $ |
$ | ( |
) | ||||||||
Actuarial (gains) and losses from changes in demographic assumptions |
– | ( |
) |
|||||||||||||
Actuarial (gains) and losses from changes in financial assumptions |
( |
) |
( |
) | ( |
) |
( |
) | ||||||||
Actuarial (gains) and losses from changes in experience |
( |
) |
( |
) | ||||||||||||
Additional details on fair value of pension plan assets invested |
||||||||||||||||
In Scotiabank securities (stock, bonds) |
– |
– | ||||||||||||||
In property occupied by Scotiabank |
– |
– | ||||||||||||||
Change in asset ceiling/onerous liability |
||||||||||||||||
Asset ceiling /onerous liability at end of prior year |
– |
– | ||||||||||||||
Interest expense |
– |
– | ||||||||||||||
Remeasurements |
( |
) |
– |
– | ||||||||||||
Foreign exchange |
( |
) |
– |
– | ||||||||||||
Asset ceiling /onerous liability at end of year |
$ |
$ | $ |
– |
$ | – |
(1) | The recognized asset is limited by the present value of economic benefits available from a reduction in future contributions to a plan and from the ability to pay plan expenses from the fund. |
e) |
Maturity profile of the defined benefit obligation |
Pension plans |
Other benefit plans |
|||||||||||||||
For the year ended October 31 | 2023 |
2022 |
2023 |
2022 |
||||||||||||
Disaggregation of the benefit obligation (%) |
||||||||||||||||
Canada |
||||||||||||||||
Active members |
% |
% | % |
% | ||||||||||||
Inactive and retired members |
% |
% | % |
% | ||||||||||||
Total |
% |
% | % |
% | ||||||||||||
Mexico |
||||||||||||||||
Active members |
% |
% | % |
% | ||||||||||||
Inactive and retired members |
% |
% | % |
% | ||||||||||||
Total |
% |
% | % |
% | ||||||||||||
United States |
||||||||||||||||
Active members |
% |
% | % |
% | ||||||||||||
Inactive and retired members |
% |
% | % |
% | ||||||||||||
Total |
% |
% | % |
% |
f) |
Key assumptions (%) |
Pension plans |
Other benefit plans |
|||||||||||||||
For the year ended October 31 | 2023 |
2022 |
2023 |
2022 |
||||||||||||
Benefit obligation at end of year |
||||||||||||||||
Discount rate – all plans |
% |
% | % |
% | ||||||||||||
Discount rate – Canadian plans only |
% |
% | % |
% | ||||||||||||
Rate of increase in future compensation (1)(2) |
% |
% | % |
% | ||||||||||||
Benefit expense (income) for the year |
||||||||||||||||
Discount rate – All plans |
||||||||||||||||
Discount rate for defined benefit obligations |
% |
% | % |
% | ||||||||||||
Discount rate for net interest cost |
% |
% | % |
% | ||||||||||||
Discount rate for service cost |
% |
% | % |
% | ||||||||||||
Discount rate for interest on service cost |
% |
% | % |
% | ||||||||||||
Discount rate – Canadian plans only |
||||||||||||||||
Discount rate for defined benefit obligations |
% |
% | % |
% | ||||||||||||
Discount rate for net interest cost |
% |
% | % |
% | ||||||||||||
Discount rate for service cost |
% |
% | % |
% | ||||||||||||
Discount rate for interest on service cost |
% |
% | % |
% | ||||||||||||
Rate of increase in future compensation (1)(2) |
% |
% | % |
% | ||||||||||||
Health care cost trend rates at end of year |
||||||||||||||||
Initial rate |
n/a |
n/a | % |
% | ||||||||||||
Ultimate rate |
n/a |
n/a | % |
% | ||||||||||||
Year ultimate rate reached |
n/a |
n/a | ||||||||||||||
Assumed life expectancy in Canada (years) |
||||||||||||||||
Life expectancy at 65 for current pensioners – male |
||||||||||||||||
Life expectancy at 65 for current pensioners – female |
||||||||||||||||
Life expectancy at 65, for future pensioners currently aged 45 – male |
||||||||||||||||
Life expectancy at 65, for future pensioners currently aged 45 – female |
||||||||||||||||
Assumed life expectancy in Mexico (years) |
||||||||||||||||
Life expectancy at 65 for current pensioners – male |
||||||||||||||||
Life expectancy at 65 for current pensioners – female |
||||||||||||||||
Life expectancy at 65, for future pensioners currently aged 45 – male |
||||||||||||||||
Life expectancy at 65, for future pensioners currently aged 45 – female |
||||||||||||||||
Assumed life expectancy in United States (years) |
||||||||||||||||
Life expectancy at 65 for current pensioners – male |
||||||||||||||||
Life expectancy at 65 for current pensioners – female |
||||||||||||||||
Life expectancy at 65, for future pensioners currently aged 45 – male |
||||||||||||||||
Life expectancy at 65, for future pensioners currently aged 45 – female |
(1) | The weighted-average rates of increase in future compensation shown for other benefit plans do not include Canadian flexible post-retirement benefits plans established in fiscal 2005, as they are not impacted by future compensation increases. |
(2) | The weighted average rates of increase in future compensation shown only consider long-term rates. In some regions, higher rates of increase are assumed in the short term but are not included in the weighted average rates disclosed. |
g) |
Sensitivity analysis |
Pension plans |
Other benefit plans |
|||||||||||||||
For the year ended October 31, 2023 ($ millions) | Benefit obligation |
Benefit expense |
Benefit obligation |
Benefit expense |
||||||||||||
Impact of the following changes: |
||||||||||||||||
1% decrease in discount rate |
$ |
$ |
$ |
$ |
||||||||||||
0.25% increase in rate of increase in future compensation |
– |
– |
||||||||||||||
1% increase in health care cost trend rate |
n/a |
n/a |
||||||||||||||
1% decrease in health care cost trend rate |
n/a |
n/a |
( |
) |
( |
) | ||||||||||
1 year increase in Canadian life expectancy |
||||||||||||||||
1 year increase in Mexican life expectancy |
– |
– |
||||||||||||||
1 year increase in the United States life expectancy |
– |
– |
h) |
Assets |
Pension plans |
Other benefit plans |
|||||||||||||||
Asset category % | Actual 2023 |
Actual 2022 |
Actual 2023 |
Actual 2022 |
||||||||||||
Cash and cash equivalents |
% |
% | % |
– | % | |||||||||||
Equity investments |
||||||||||||||||
Quoted in an active market |
% |
% | % |
% | ||||||||||||
Non quoted |
% |
% | – |
% |
– | % | ||||||||||
% |
% | % |
% | |||||||||||||
Fixed income investments |
||||||||||||||||
Quoted in an active market |
% |
% | % |
% | ||||||||||||
Non quoted |
% |
% | – |
% |
– | % | ||||||||||
% |
% | % |
% | |||||||||||||
Property |
||||||||||||||||
Quoted in an active market |
– |
% |
– | % | % |
% | ||||||||||
Non quoted |
% |
% | – |
% |
– | % | ||||||||||
% |
% | % |
% | |||||||||||||
Other |
||||||||||||||||
Quoted in an active market |
– |
% |
– | % | – |
% |
– | % | ||||||||
Non quoted |
% |
% | – |
% |
– | % | ||||||||||
% |
% | – |
% |
– | % | |||||||||||
Total |
% |
% | % |
% |
Target asset allocation at October 31, 2023 Asset category % |
Pension plans |
Other benefit plans |
||||||
Cash and cash equivalents |
– |
% |
– |
% | ||||
Equity investments |
% |
% | ||||||
Fixed income investments |
% |
% | ||||||
Property |
% |
% | ||||||
Other |
% |
– |
% | |||||
Total |
% |
% |
29 |
Operating Segments |
• | tax normalization adjustments related to the gross-up of income from associated corporations. This adjustment normalizes the effective tax rate in the divisions to better present the contribution of the associated companies to the divisional results. |
• | the grossing up of tax-exempt net interest income and non-interest income to an equivalent before-tax basis for those affected segments. |
For the year ended October 31, 2023 | ||||||||||||||||||||||||
Taxable equivalent basis ($ millions) | Canadian Banking (1) |
International Banking (1) |
Global Wealth Management (1) |
Global Banking and Markets (1) |
Other (1)(2) |
Total |
||||||||||||||||||
Net interest income (3) |
$ |
$ |
$ |
$ |
$ |
( |
) |
$ |
||||||||||||||||
Non-interest income(4)(5) |
( |
) |
||||||||||||||||||||||
Total revenues |
( |
) |
||||||||||||||||||||||
Provision for credit losses |
– |
|||||||||||||||||||||||
Depreciation and amortization (6) |
||||||||||||||||||||||||
Other non-interest expenses |
||||||||||||||||||||||||
Income tax expense |
( |
) |
||||||||||||||||||||||
Net income |
$ |
$ |
$ |
$ |
$ |
( |
) |
$ |
||||||||||||||||
Net income attributable to non-controlling interests in subsidiaries |
– |
– |
( |
) |
||||||||||||||||||||
Net income attributable to equity holders of the Bank |
$ |
$ |
$ |
$ |
$ |
( |
) |
$ |
||||||||||||||||
Average assets ($ billions) |
||||||||||||||||||||||||
Average liabilities ($ billions) |
(1) | Business line revenues and provision for income taxes are reported on a tax equivalent basis. |
(2) | Includes all other smaller operating segments and corporate adjustments, such as the elimination of the tax-exempt income gross-up reported in net interest income and non-interest income and provision for income taxes for the year ended October 31, 2023 amounting to $ |
(3) | Interest income is reported net of interest expense as management relies primarily on net interest income as a performance measure. |
(4) | Card revenues and Banking services fees are mainly earned in Canadian and International Banking. Mutual fund, Brokerage fees and Investment management and trust fees are primarily earned in Global Wealth Management. Underwriting and other advisory fees are predominantly earned in Global Banking and Markets. |
(5) | Includes net income (on a taxable equivalent basis) from investments in associated corporations for Canadian Banking – $ ; Global Banking and Markets - $ $( |
(6) |
Includes impairment charge of software and other intangible assets in the Other segment. |
For the year ended October 31, 2022 | ||||||||||||||||||||||||
Taxable equivalent basis ($ millions) | Canadian Banking (1) |
International Banking (1) |
Global Wealth Management (1) |
Global Banking and Markets (1) |
Other (1)(2) |
Total |
||||||||||||||||||
Net interest income (3) |
$ | $ | $ | $ | $ | ( |
) | $ | ||||||||||||||||
Non-interest income(4)(5) |
( |
) | ||||||||||||||||||||||
Total revenues |
|
|
|
|
( |
) | |
|||||||||||||||||
Provision for credit losses |
( |
) | ||||||||||||||||||||||
Depreciation and amortization (6) |
||||||||||||||||||||||||
Other non-interest expenses(6) |
|
|||||||||||||||||||||||
Income tax expense |
( |
) | ||||||||||||||||||||||
Net income |
$ | $ | $ | $ | $ | ( |
) | $ | ||||||||||||||||
Net income attributable to non-controlling interests in subsidiaries |
– | – | – | |||||||||||||||||||||
Net income attributable to equity holders of the Bank |
$ | $ | $ | $ | $ | ( |
) | $ | ||||||||||||||||
Average assets ($ billions) |
||||||||||||||||||||||||
Average liabilities ($ billions) |
(1) | Business line revenues and provision for income taxes are reported on a tax equivalent basis. |
(2) | Includes all other smaller operating segments and corporate adjustments, such as the elimination of the tax-exempt income gross-up reported in net interest income and non-interest income and provision for income taxes for the year ended October 31, 2022 amounting to $ |
(3) | Interest income is reported net of interest expense as management relies primarily on net interest income as a performance measure. |
(4) | Card revenues and Banking services fees are mainly earned in Canadian and International Banking. Mutual fund, Brokerage fees and Investment management and trust fees are primarily earned in Global Wealth Management. Underwriting and other advisory fees are predominantly earned in Global Banking and Markets. |
(5) | Includes net income (on a taxable equivalent basis) from investments in associated corporations for Canadian Banking – $ |
(6) |
Prior period amounts have been restated to conform with current period presentation. |
For the year ended October 31, 2023 ($ millions) (1) |
Canada |
United States |
Mexico |
Peru |
Chile |
Colombia |
Caribbean and Central America |
Other International |
Total |
|||||||||||||||||||||||||||
Net interest income |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||||||
Non-interest (1) |
||||||||||||||||||||||||||||||||||||
Total revenues (2) |
||||||||||||||||||||||||||||||||||||
Provision for credit losses |
||||||||||||||||||||||||||||||||||||
Non-interest |
||||||||||||||||||||||||||||||||||||
Income tax expense |
( |
) |
||||||||||||||||||||||||||||||||||
Subtotal |
( |
) |
||||||||||||||||||||||||||||||||||
Net income attributable to non-controlling interests |
( |
) |
– |
( |
) |
– |
||||||||||||||||||||||||||||||
Net income attributable to equity holders of the Bank |
$ |
$ |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
$ |
|||||||||||||||||||||||||
Total average assets ($ billions) |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
(1) | Includes net income from investments in associated corporations for Canada – $( |
(2) | Revenues are attributed to countries based on where services are performed or assets are recorded. |
For the year ended October 31, 2022 ($ millions) (1) |
Canada |
United States |
Mexico |
Peru |
Chile |
Colombia |
Caribbean and Central America |
Other International |
Total |
|||||||||||||||||||||||||||
Net interest income |
$ | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Non-interest income(1) |
||||||||||||||||||||||||||||||||||||
Total revenues (2) |
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Provision for credit losses |
( |
) | ||||||||||||||||||||||||||||||||||
Non-interest expenses |
||||||||||||||||||||||||||||||||||||
Income tax expense |
||||||||||||||||||||||||||||||||||||
Subtotal |
||||||||||||||||||||||||||||||||||||
Net income attributable to non-controlling interests in subsidiaries |
– | – | ||||||||||||||||||||||||||||||||||
Net income attributable to equity holders of the Bank |
$ | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Total average assets ($ billions) |
$ | $ | $ | $ | $ | $ | $ | $ | $ |
(1) | Includes net income from investments in associated corporations for Canada – $ |
(2) | Revenues are attributed to countries based on where services are performed or assets are recorded. |
30 |
Related Party Transactions |
For the year ended October 31 ($ millions) | 2023 |
2022 |
||||||
Salaries and cash incentives (1) |
$ |
$ | |
|||||
Equity-based payment (2) |
||||||||
Pension and other benefits (1) |
||||||||
Total |
$ |
$ |
(1) | Expensed during the year. |
(2) | Awarded during the year. |
As at October 31 ($ millions) |
2023 |
2022 |
||||||
Loans |
$ |
$ |
||||||
Deposits |
$ |
$ |
As at and for the year ended October 31 ($ millions) |
2023 |
2022 |
||||||
Net income / (loss) |
$ |
( |
) |
$ |
( |
) | ||
Loans |
||||||||
Deposits |
||||||||
Guarantees and commitments |
31 |
Principal Subsidiaries and Non-Controlling Interests in Subsidiaries |
(a) |
Principal subsidiaries (1) |
Carrying value of shares |
||||||||||
As at October 31 ($ millions) | Principal office |
2023 |
2022 |
|||||||
Canadian |
||||||||||
$ |
$ | |||||||||
|
||||||||||
(2) |
||||||||||
International |
||||||||||
(3) |
(4) | |||||||||
( 5 ) |
||||||||||
(1) | The Bank (or immediate parent of an entity) owns |
(2) | The Bank of Nova Scotia Trust Company & ADS Canadian Bank amalgamated effective November 1, 2022 and continue as The Bank of Nova Scotia Trust Company. |
(3) | Effective July 1, 2023, Scotia Holdings (U.S.) Inc. converted to a Limited Liability Company and changed its name to Scotia Holdings (USA) LLC. |
(4) |
The 2022 Scotia Capital (USA) Inc. carrying value was part of BNS Investments Inc. |
(5) |
The Bank made a capital contribution to Scotiabank Colpatria S.A. in July 2023 which increased its ownership interest to |
(b) |
Non-controlling interests in subsidiaries |
As at and for the year ended |
||||||||||||||||||||
2023 |
2022 |
|||||||||||||||||||
Non-controlling interest % |
Non-controlling interests in subsidiaries |
Dividends paid to non-controlling interest |
Non-controlling interests in subsidiaries |
Dividends paid to non-controlling interest |
||||||||||||||||
Scotiabank Chile S.A. |
% (1) |
$ |
$ |
$ | $ | |||||||||||||||
Scotiabank Colpatria S.A. (2)(3) |
% |
– |
||||||||||||||||||
Scotia Group Jamaica Limited |
% |
|||||||||||||||||||
Scotiabank Trinidad and Tobago Limited |
% |
|||||||||||||||||||
Other |
– ( 4) |
|||||||||||||||||||
Total |
$ |
$ |
$ | |
$ | |
(1) | The Bank increased its ownership in Scotiabank Chile S.A. in 2022 by acquiring an additional % stake from the primary non-controlling shareholders. Refer to Note 36 for details. The remaining non-controlling interest related primarily to non-controlling interests in Scotiabank Chile S.A. subsidiaries. |
(2) |
Non-controlling interest holders for Scotiabank Colpatria S.A. have a right to sell their holding to the Bank after the end of 7th anniversary (January 17, 2019) and at subsequent pre-agreed intervals, into the future, at fair market value that can be settled at the Bank’s discretion, by issuance of common shares or cash. |
(3) | The Bank made a capital contribution to Scotiabank Colpatria S.A. in July 2023 which increased its ownership interest to |
(4) |
Range of non-controlling interest % for other subsidiaries. |
As at and for the year ended October 31, 2023 |
As at and for the year ended October 31, 2022 |
|||||||||||||||||||||||||||||||
($ millions) | Revenue |
Total comprehensive income (loss) |
Total assets |
Total liabilities |
Revenue |
Total comprehensive income (loss) |
Total assets |
Total liabilities |
||||||||||||||||||||||||
Total |
$ |
$ |
$ |
$ |
$ | |
$ | |
$ | |
$ | |
32 |
Interest Income and Expense |
For the year ended October 31 ($ millions) | 2023 |
2022 |
||||||||||||||
Interest income |
Interest expense |
Interest income |
Interest expense |
|||||||||||||
Measured at amortized cost (1) |
$ |
$ |
$ | $ | ||||||||||||
Measured at FVOCI (1) |
– |
– | ||||||||||||||
Other |
(2) |
(3) |
(2) |
(3) | ||||||||||||
Total |
$ |
$ |
$ | |
$ | |
(1) | The interest income/expense on financial assets/liabilities are calculated using the effective interest method. |
(2) | Includes dividend income on equity securities. |
(3) | The interest on lease liabilities was $ |
33 |
Earnings Per Share |
For the year ended October 31 ($ millions) | 2023 |
2022 |
||||||
Basic earnings per common share |
||||||||
Net income attributable to common shareholders |
$ |
$ | ||||||
Weighted average number of common shares outstanding (millions) |
||||||||
Basic earnings per common share (1) (in dollars) |
$ |
$ | ||||||
Diluted earnings per common share |
||||||||
Net income attributable to common shareholders |
$ |
$ | ||||||
Dilutive impact of share-based payment options and others (2) |
( |
) |
||||||
Net income attributable to common shareholders (diluted) |
$ |
$ | |
|||||
Weighted average number of common shares outstanding (millions) |
||||||||
Dilutive impact of share-based payment options and others (2) (millions) |
||||||||
Weighted average number of diluted common shares outstanding (millions) |
||||||||
Diluted earnings per common share (1) (in dollars) |
$ |
$ |
(1) | Earnings per share calculations are based on full dollar and share amounts. |
(2) | Certain options as well as acquisition-related put/call options that the Bank may settle at its own discretion by issuing common shares were not included in the calculation of diluted earnings per share as they were anti-dilutive. |
34 |
Guarantees, Commitments and Pledged Assets |
(a) |
Guarantees |
2023 |
2022 |
|||||||
As at October 31 ($ millions) | Maximum potential amount of future payments (1) |
Maximum potential amount of future payments (1) |
||||||
Standby letters of credit and letters of guarantee |
$ |
$ | |
|||||
Liquidity facilities |
||||||||
Indemnifications |
(1) | The maximum potential amount of future payments represents those guarantees that can be quantified and excludes other guarantees that cannot be quantified. As many of these guarantees will not be drawn upon and the maximum potential amount of future payments listed above does not consider the possibility of recovery under recourse or collateral provisions, the above amounts are not indicative of future cash requirements, credit risk, or the Bank’s expected losses from these arrangements. |
(i) |
Standby letters of credit and letters of guarantee |
(ii) |
Liquidity facilities |
(iii) |
Indemnifications |
(b) |
Other indirect commitments |
• | Commercial letters of credit which require the Bank to honour drafts presented by a third-party when specific activities are completed; |
• | Commitments to extend credit which represent undertakings to make credit available in the form of loans or other financings for specific amounts and maturities, subject to specific conditions; |
• | Securities lending transactions under which the Bank, acting as principal or agent, agrees to lend securities to a borrower. The borrower must fully collateralize the security loan at all times. The market value of the collateral is monitored relative to the amounts due under the agreements, and where necessary, additional collateral is obtained; and |
• | Security purchase commitments which require the Bank to fund future investments. |
As at October 31 ($ millions) | 2023 |
2022 |
||||||
Commercial letters of credit |
$ |
$ | ||||||
Commitments to extend credit (1) |
||||||||
Original term to maturity of one year or less |
||||||||
Original term to maturity of more than one year |
||||||||
Securities lending |
||||||||
Securities purchase and other commitments |
||||||||
Total |
$ |
$ | |
(1) | Includes liquidity facilities, and excludes commitments which are unconditionally cancellable at the Bank’s discretion at any time. |
(c) |
Assets pledged and repurchase agreements |
As at October 31 ($ millions) | 2023 |
2022 |
||||||
Assets pledged to: |
||||||||
Bank of Canada (1) |
$ |
$ | ||||||
Foreign governments and central banks (1) |
||||||||
Clearing systems, payment systems and depositories (1) |
||||||||
Assets pledged in relation to exchange-traded derivative transactions |
||||||||
Assets pledged in relation to over-the-counter |
||||||||
Assets pledged as collateral related to securities borrowing and lending |
||||||||
Assets pledged in relation to covered bond program (Note 15) (2) |
||||||||
Assets pledged in relation to other securitization programs (Note 15) |
||||||||
Assets pledged under CMHC programs (Note 14) |
||||||||
Other |
||||||||
Total assets pledged |
$ |
$ | |
|||||
Obligations related to securities sold under repurchase agreements |
||||||||
Total (3) |
$ |
$ |
(1) | Includes assets pledged in order to participate in clearing and payment systems and depositories, or pledged to have access to the facilities of central banks in foreign jurisdictions. |
(2) | Excludes mortgages related to covered bonds held by the Bank or used for securities lending transactions. |
(3) |
Includes assets that have been received from counterparties through normal course of business in securities financing and derivative transactions. |
(d) |
Other executory contracts |
35 |
Financial Instruments – Risk Management |
• | extensive risk management policies define the Bank’s risk appetite, set the limits and controls within which the Bank and its subsidiaries can operate, and reflect the requirements of regulatory authorities. These policies are approved by the Bank’s Board of Directors, either directly or through the Risk Committee of the Board, (the Board); |
• | guidelines are developed to clarify risk limits and conditions under which the Bank’s risk policies are implemented; |
• | processes are implemented to identify, evaluate, document, report and control risk. Standards define the breadth and quality of information required to make a decision; and |
• | compliance with risk policies, limits and guidelines is measured, monitored and reported to ensure consistency against defined goals. |
(a) |
Credit risk |
• | target markets and product offerings are well defined; |
• | the risk parameters for new underwritings and for the portfolios as a whole are clearly specified; and |
• | transactions, including origination, syndication, loan sales and hedging, are managed in a manner to ensure the goals for the overall portfolio are met. |
(i) |
Credit risk exposures |
As at October 31 ($ millions) |
2023 |
2022 |
||||||||||||||||||
Revised Basel III (1) |
Basel III |
|||||||||||||||||||
Exposure at default (2) |
||||||||||||||||||||
Category |
Drawn (3) |
Undrawn commitments |
Other exposures (4) |
Total |
Total |
|||||||||||||||
By counterparty type |
||||||||||||||||||||
Non-retail |
||||||||||||||||||||
IRB portfolio |
||||||||||||||||||||
Corporate |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||
Bank |
||||||||||||||||||||
Sovereign |
||||||||||||||||||||
Standardized portfolio |
||||||||||||||||||||
Corporate |
||||||||||||||||||||
Bank |
||||||||||||||||||||
Sovereign |
||||||||||||||||||||
Total non-retail |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||
Retail |
||||||||||||||||||||
IRB portfolio |
||||||||||||||||||||
Real estate secured |
$ |
$ |
$ |
– |
$ |
$ |
||||||||||||||
Qualifying revolving |
– |
|||||||||||||||||||
Other retail |
– |
|||||||||||||||||||
– |
||||||||||||||||||||
Standardized portfolio |
||||||||||||||||||||
Real estate secured |
– |
|||||||||||||||||||
Other retail |
||||||||||||||||||||
Total retail |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||
Total |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||
By geography (5) |
||||||||||||||||||||
Canada |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||
United States |
||||||||||||||||||||
Chile |
||||||||||||||||||||
Mexico |
||||||||||||||||||||
Peru |
||||||||||||||||||||
Colombia |
||||||||||||||||||||
Other International |
||||||||||||||||||||
Europe |
||||||||||||||||||||
Caribbean |
||||||||||||||||||||
Latin America (other) |
||||||||||||||||||||
All other |
||||||||||||||||||||
Total |
$ |
$ |
$ |
$ |
$ |
(1) |
Regulatory amounts reported in 2023 are under Revised Basel III requirements and are not directly comparable to amounts reported in 2022. |
(2) |
Exposure at default is presented after credit risk mitigation. Exposures exclude equity securities and other assets. Portfolios under the Standardized Approach are reported net of specific allowances for credit losses and net of collateral amounts treated under the Comprehensive Approach. |
(3) |
Non-retail drawn includes loans, acceptances, deposits with financial institutions and FVOCI debt securities. Retail drawn includes residential mortgages, credit cards, lines of credit, and other personal loans. |
(4) |
Other exposures include off-balance sheet lending instruments such as letters of credit, letters of guarantees, securitizations (2023 excluding first loss of $ $million , and in 2022, including first loss protection of |
(5) |
Geographic segmentation is based upon the location of the ultimate risk of the credit exposure. |
Credit Risk Exposures |
Other Exposures |
|||||||||||||||||||||||||||||||||||||||||||||||
Drawn |
Other Exposures |
Market Risk Exposures |
||||||||||||||||||||||||||||||||||||||||||||||
As at October 31, 2023 ($ millions) | Non-retail |
Retail |
Securitization |
Repo-style Transactions |
OTC Derivatives |
Equity |
Also subject to Credit Risk |
All Other (1) |
Total |
|||||||||||||||||||||||||||||||||||||||
Cash and deposits with financial institutions |
$ |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
$ |
$ |
|||||||||||||||||||||||||||||||
Precious metals |
– |
– |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||
Trading assets |
||||||||||||||||||||||||||||||||||||||||||||||||
Securities |
– |
– |
– |
– |
– |
– |
– |
( |
) |
|||||||||||||||||||||||||||||||||||||||
Loans |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||||
Other |
– |
– |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||
Financial assets designated at fair value through profit or loss |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||
Securities purchased under resale agreements and securities borrowed |
– |
– |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||
Derivative financial instruments |
– |
– |
– |
– |
– |
– |
– |
|||||||||||||||||||||||||||||||||||||||||
Investment securities |
– |
– |
– |
– |
– |
– |
( |
) |
||||||||||||||||||||||||||||||||||||||||
Loans: |
||||||||||||||||||||||||||||||||||||||||||||||||
Residential mortgages (2) |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||||
Personal loans |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||||
Credit cards |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||||
Business & government |
– |
– |
– |
– |
– |
( |
) |
|||||||||||||||||||||||||||||||||||||||||
Allowances for credit losses (3) |
( |
) |
( |
) |
– |
– |
– |
– |
– |
– |
( |
) |
( |
) | ||||||||||||||||||||||||||||||||||
Customers’ liability under acceptances |
– |
– |
– |
– |
– |
– |
– |
( |
) |
|||||||||||||||||||||||||||||||||||||||
Property and equipment |
– |
– |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||
Investment in associates |
– |
– |
– |
– |
– |
– |
– |
|||||||||||||||||||||||||||||||||||||||||
Goodwill and other intangibles assets |
– |
– |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||
Other (including Deferred tax assets) |
– |
– |
– |
– |
– |
|||||||||||||||||||||||||||||||||||||||||||
Total |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
(1) | Includes the Bank’s insurance subsidiaries’ assets and all other assets which are not subject to credit and market risks. |
(2) | Includes $ |
(3) | Amounts for IRB exposures are reported gross of allowances and amounts for standardized exposures are reported net of allowances. |
Credit Risk Exposures |
Other Exposures |
|||||||||||||||||||||||||||||||||||||||||||||||
Drawn |
Other Exposures |
Market Risk Exposures |
||||||||||||||||||||||||||||||||||||||||||||||
As at October 31, 2022 ($ millions) |
Non-retail |
Retail |
Securitization |
Repo-style Transactions |
OTC Derivatives |
Equity |
Also subject to Credit Risk |
All Other (1) |
Total |
|||||||||||||||||||||||||||||||||||||||
Cash and deposits with financial institutions |
$ |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
$ |
$ |
|||||||||||||||||||||||||||||||
Precious metals |
– |
– |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||
Trading assets |
||||||||||||||||||||||||||||||||||||||||||||||||
Securities |
( |
) |
– |
– |
– |
– |
– |
– |
– |
|||||||||||||||||||||||||||||||||||||||
Loans |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||||
Other |
– |
– |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||
Financial assets designated at fair value through profit or loss |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||
Securities purchased under resale agreements and securities borrowed |
– |
– |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||
Derivative financial instruments |
– |
– |
– |
– |
– |
– |
– |
|||||||||||||||||||||||||||||||||||||||||
Investment securities |
– |
– |
– |
– |
– |
– |
( |
) |
||||||||||||||||||||||||||||||||||||||||
Loans: |
||||||||||||||||||||||||||||||||||||||||||||||||
Residential mortgages (2) |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||||
Personal loans |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||||
Credit cards |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||||
Business & government |
– |
– |
– |
– |
– |
( |
) |
|||||||||||||||||||||||||||||||||||||||||
Allowances for credit losses (3) |
( |
) |
( |
) |
– |
– |
– |
– |
– |
– |
( |
) |
( |
) | ||||||||||||||||||||||||||||||||||
Customers’ liability under acceptances |
– |
– |
– |
– |
– |
– |
– |
( |
) |
|||||||||||||||||||||||||||||||||||||||
Property and equipment |
– |
– |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||
Investment in associates |
– |
– |
– |
– |
– |
– |
– |
|||||||||||||||||||||||||||||||||||||||||
Goodwill and other intangibles assets |
– |
– |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||
Other (including Deferred tax assets) |
– |
– |
– |
– |
– |
|||||||||||||||||||||||||||||||||||||||||||
Total |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
(1) | Includes the Bank’s insurance subsidiaries’ assets and all other assets which are not subject to credit and market risks. |
(2) | Includes $ |
(3) | Amounts for AIRB exposures are reported gross of allowances and amounts for standardized exposures are reported net of allowances. |
(ii) |
Credit quality of non-retail exposures |
Cross referencing of internal ratings to external ratings (1) | ||||||||||||
Equivalent External Rating |
||||||||||||
S&P |
Moody’s |
DBRS |
Internal Grade |
Internal Grade Code |
PD Range (2) | |||||||
Investment grade |
||||||||||||
Non-Investment grade |
||||||||||||
– |
||||||||||||
– |
Watch list |
|||||||||||
– |
||||||||||||
– |
– |
– |
||||||||||
Default |
(1) | Applies to non-retail portfolio. |
(2) | PD Ranges as at October 31, 2023. The Range does not include the upper boundary for the row. |
2023 |
2022 |
|||||||||||||||||||||||
Revised Basel III (1) |
Basel III |
|||||||||||||||||||||||
Exposure at Default (2) |
||||||||||||||||||||||||
As at October 31 ($ millions) Category of internal grades |
IG Code |
Drawn |
Undrawn commitments |
Other exposures (3) |
Total |
Total |
||||||||||||||||||
Investment grade |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||
Non-Investment |
||||||||||||||||||||||||
Watch list |
||||||||||||||||||||||||
Default |
||||||||||||||||||||||||
Total |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||
Government guaranteed residential mortgages (4) |
– |
– |
||||||||||||||||||||||
Total |
$ |
$ |
$ |
$ |
$ |
(1) |
Regulatory amounts reported in 2023 are under Revised Basel III requirements and are not directly comparable to amounts reported in 2022. |
(2) |
After credit risk mitigation. |
( 3 ) |
Includes off-balance sheet lending instruments such as letters of credit, letters of guarantees, securitizations (excluding first loss protection ) , derivatives and repo-style transactions (reverse repurchase agreements, repurchase agreements and securities lending and borrowing), net of related collateral. |
( 4 ) |
These exposures are classified as sovereign exposures and are included in the non-retail category. |
(iii) |
Credit quality of retail exposures |
As at October 31 ($ millions) | 2023 |
2022 |
||||||||||||||||||||||||||
Revised Basel III (1) |
Basel III |
|||||||||||||||||||||||||||
Exposure at default (2) |
||||||||||||||||||||||||||||
Real estate secured |
||||||||||||||||||||||||||||
Category of (PD) grades | PD range |
Mortgages |
HELOC |
Qualifying revolving |
Other retail |
Total |
Total |
|||||||||||||||||||||
Exceptionally Low (3) |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
$ | |||||||||||||||||
Very Low |
||||||||||||||||||||||||||||
Low |
||||||||||||||||||||||||||||
Medium Low |
– |
|||||||||||||||||||||||||||
Medium |
||||||||||||||||||||||||||||
High |
||||||||||||||||||||||||||||
Extremely High |
||||||||||||||||||||||||||||
Default |
||||||||||||||||||||||||||||
Total |
$ |
$ |
$ |
$ |
$ |
$ | |
(1) |
Regulatory amounts reported in 2023 are under Revised Basel III requirements and are not directly comparable to amounts reported in 2022. |
(2) |
After credit risk mitigation. |
(3) |
OSFI has revised the Retail Probablility of Default floor from |
(iv) |
Collateral |
• | The risks and rewards of the pledged assets reside with the pledgor. |
• | Additional collateral is required when the market value of the transaction exceeds thresholds agreed upon with the pledgor. |
• | The Bank is normally permitted to sell or repledge the collateral it receives, although this right is specific to each agreement under which the collateral is pledged. |
• | Upon satisfaction of the obligation, the Bank must return the pledged assets, unless the Bank has the right to sell or repledge the collateral it receives, in which case the Bank must return comparable collateral to the pledgor. |
(b) |
Liquidity risk |
• | liquidity risk measurement and management limits, including limits on maximum net cash outflow by currency over specified short-term horizons; |
• | prudent diversification of its wholesale funding activities by using a number of different funding programs to access the global financial markets and manage its maturity profile, as appropriate; |
• | large holdings of liquid assets to support its operations, which can generally be sold or pledged to meet the Bank’s obligations; |
• | liquidity stress testing, including Bank-specific, global-systemic, and combination systemic/Bank-specific scenarios; and |
• | liquidity contingency planning. |
(i) |
Commitments to extend credit |
(ii) |
Derivative instruments |
(c) |
Market risk |
(i) |
Non-trading interest rate risk |
As at October 31 ($ millions) | 2023 |
2022 |
||||||||||||||||||||||||||||||
Net interest income |
Economic value of equity |
|||||||||||||||||||||||||||||||
Canadian dollar |
Other currencies |
Total |
Canadian dollar |
Other currencies |
Total |
Net interest income |
Economic value of equity |
|||||||||||||||||||||||||
100 bp increase |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ | ( |
) | $ | ( |
) | ||||||||||
100 bp decrease |
$ |
$ |
( |
) |
$ |
$ |
$ |
$ |
$ | |
$ | |
(ii) |
Non-trading foreign currency risk |
(iii) |
Non-trading equity risk |
(iv) |
Trading portfolio risk management |
For the year ended October 31, 2023 |
||||||||||||||||||||
($ millions) | As at October 31, 2023 |
Average |
High |
Low |
As at October 31, 2022 |
|||||||||||||||
Credit spread plus interest rate |
$ |
$ |
$ |
$ |
$ | |||||||||||||||
Credit spread |
||||||||||||||||||||
Interest rate |
||||||||||||||||||||
Equities |
||||||||||||||||||||
Foreign exchange |
||||||||||||||||||||
Commodities |
||||||||||||||||||||
Debt specific |
||||||||||||||||||||
Diversification effect |
( |
) |
( |
) |
n/a |
n/a |
( |
) | ||||||||||||
All-Bank VaR |
$ |
$ |
$ |
$ |
$ | |||||||||||||||
All-Bank stressed VaR |
$ |
$ |
$ |
$ |
$ | |
($ millions) | 2023 |
2022 |
||||||
All-Bank VaR |
$ |
$ | ||||||
All-Bank stressed VaR |
||||||||
Incremental risk charge |
||||||||
Standardized approach |
||||||||
Total market risk capital |
$ |
$ | |
(1) |
(1) | Equates to $ |
(d) |
Operational risk |
36 |
Acquisitions and Divestitures |